Page last updated: 2024-11-04

alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid: An IBOTENIC ACID homolog and glutamate agonist. The compound is the defining agonist for the AMPA subtype of glutamate receptors (RECEPTORS, AMPA). It has been used as a radionuclide imaging agent but is more commonly used as an experimental tool in cell biological studies. [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID158397
CHEMBL ID276815
SCHEMBL ID667915
MeSH IDM0027584
PubMed CID1221
CHEMBL ID13378
CHEBI ID34018
SCHEMBL ID68799
MeSH IDM0027584

Synonyms (155)

Synonym
HMS3266E09
NCGC00024517-01
NCGC00024481-01
tocris-1074
NCGC00024481-02
tocris-0254
tocris-0169
NCGC00015458-01
lopac-g-017
BPBIO1_001304
(s)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
AMQ ,
(s)-ampa, >=98%
1FTM
DB02057
l-ampa
s-ampa
1P1Q
NCGC00024517-02
(s)-ampa
BIOMOL-NT_000216
2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid
chembl276815 ,
bdbm17662
(2s)-2-amino-3-(3-hydroxy-5-methyl-1,2-oxazol-4-yl)propanoic acid
(2s)-2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid
(2s)-2-azaniumyl-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoate
(s)-2-amino-3-(5-methyl-3-oxo-2,3-dihydroisoxazol-4-yl)propanoic acid
A840622
83643-88-3
M01254
UUDAMDVQRQNNHZ-YFKPBYRVSA-N
3-(3-hydroxy-5-methyl-1,2-oxazol-4-yl)alanine
ampa, l-
9280sc28gd ,
4-isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-, (s)-
unii-9280sc28gd
glutamate-ampa
bdbm85214
NCGC00015458-03
NCGC00015458-02
(s)-a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
4-isoxazolepropanoic acid, .alpha.-amino-2,3-dihydro-5-methyl-3-oxo-, (.alpha.s)-
l-ampa [mi]
SCHEMBL667915
(s)-?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
HB0052
AKOS024457155
AKOS030530596
SR-01000597720-1
sr-01000597720
(s)-a-amino-3-hydroxy-5-methylisoxazole -4-propio
(s)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propanoic acid
3-(3-hydroxy-5-methylisoxazol-4-yl)-l-alanine
HMS3675C17
HMS3411C17
ampa-(s)
l-ampa, s-ampa
(2s)-2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid.
A-267
MS-23005
DTXSID701003614
bdbm50512945
HY-100815A
(2s)-2-amino-3-(5-methyl-3-oxo-2,3-dihydro-1,2-oxazol-4-yl)propanoic acid
CS-0020463
(s)-2-amino-3-(5-methyl-3-oxo-2,3-dihydroisoxazol-4-yl)propanoicacid
HMS3266A13
.alpha.-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid
PDSP2_001818
PDSP1_001835
alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
77521-29-0
ampa
LOPAC0_000581
gamma-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
(+-)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
dl-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
4-isoxazolepropanoic acid, alpha-amino-2,3-dihydro-5-methyl-3-oxo-
alpha-amino-2,3-dihydro-5-methyl-3-oxoisoxazolepropionic acid
ampa (pharmaceutical)
d,l-alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
c7h10n2o4
NCGC00024481-03
NCGC00015458-05
74341-63-2
(+/-)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
L000026
(r,s)-ampa
chebi:34018 ,
CHEMBL13378 ,
FT-0661849
(r,s)-alpha-amino-3-hydroxy-5-methyl-4-isooxazole-propionic acid
2-amino-3-(5-methyl-3-oxo-2,3-dihydroisoxazol-4-yl)propanoic acid
(rs)-2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)-propionicacid
2-ammonio-3-(3-hydroxy-5-methylisoxazol-4-yl)propanoate
2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)-propionic acid
bdbm50002370
2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)-propionic acid(dl-ampa)
2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)-propionic acid
2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid
(r)-2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)-propionic acid
( )-a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(r,s)-a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
M01253
unii-j090588e6x
alpha-amino-2,3-dihydro-5-methyl-3-oxo-4-isoxazolepropanoic acid
j090588e6x ,
ampa, d,l-
(s)-2-amino-3-(3-hydroxy-5-methyl-isoxazol-4-yl)-propionic acid
CCG-204670
NCGC00015458-04
AB02804
(rs)-ampa
2-amino-3-(5-methyl-3-oxo-2,3-dihydro-1,2-oxazol-4-yl)propanoic acid
gtpl4131
[3h]ampa
gtpl4077
AKOS017343917
SCHEMBL68799
.gamma.-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
4-isoxazolepropanoic acid, .alpha.-amino-2,3-dihydro-5-methyl-3-oxo-
dl-.alpha.-amino-3-hydroxy-5-methylisoxazole-4-propionic acid
ampa [mi]
(+/-)-.alpha.-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
(rs)-?-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
HB0030
(rs)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
2-amino-3-(5-methyl-3-oxo-isoxazol-4-yl)propanoic acid
mfcd00069214
AKOS027250886
SR-01000075447-3
(r,s)-|a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid
FT-0772278
UUDAMDVQRQNNHZ-UHFFFAOYSA-N
(rs)-a-amino-3-hydroxy-5-methylisoxazole-4-propanoic acid
DTXSID20868301
FT-0762346
HMS3675A07
HY-100815B
110592-37-5
HMS3411A07
Q66370552
2-amino-3-(3-hydroxy-5-methylisoxazol-4-yl)propanoic acid
SDCCGSBI-0050563.P002
CS-0021074
SB38931
SB38934
2-amino-3-(5-methyl-3-oxo-1,2-oxazol-4-yl)propanoic acid.
(r,s) ampa
4-isoxazolepropanoic acid, a-amino-2,3-dihydro-5-methyl-3-oxo-
ZCA34163
(r,s)-alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionicacid-13c2,15n
08 - acid herbicides in clean water
20 - acid herbicides in wastewater

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" At a concentration that was not toxic by itself, L-trans-pyrrolidine-2,4-dicarboxylate increased the toxicity of glutamate approximately fivefold and slowed the clearance of glutamate from the extracellular space."( Inhibition of glutamate uptake with L-trans-pyrrolidine-2,4-dicarboxylate potentiates glutamate toxicity in primary hippocampal cultures.
Buchhalter, JR; Djali, S; Robinson, MB, 1993
)
0.29
" We have investigated the receptor specificity of endogenous glutamate's toxic effects in organotypic cultures of the hippocampus by acute blockade of these transporters."( Neurotoxicity of acute glutamate transport blockade depends on coactivation of both NMDA and AMPA/Kainate receptors in organotypic hippocampal cultures.
Park, J; Tasker, RC; Vornov, JJ, 1995
)
0.29
" KA and AMPA were found to be more toxic than either N-methyl-D-aspartate (NMDA), quinolinate, or glutamate, both under normal conditions and under states of energy deprivation."( Kainate toxicity in energy-compromised rat hippocampal slices: differences between oxygen and glucose deprivation.
Rigor, BM; Schurr, A, 1993
)
0.29
" No toxic effects were observed when AMPA or a low concentration of NaCN (0."( Metabolic inhibition potentiates AMPA-induced Ca2+ fluxes and neurotoxicity in rat cerebellar granule cells.
Cebere, A; Cebers, G; Liljequist, S, 1998
)
0.3
" Kainate (60% maximal cell death at 1mM) was markedly more toxic than NMDA (40% maximal cell death at 1mM) and was shown to be the predominant cause of excitatory amino acid-induced toxicity in these cells as the neuronal death induced by KA was attenuated by the non-NMDA antagonist CNQX, but not the AMPA antagonist LY293558."( Investigations of non-NMDA receptor-induced toxicity in serum-free antioxidant-rich primary cultures of murine cerebellar granule cells.
Beart, PM; Carroll, FY; Cheung, NS, 1998
)
0.3
" In contrast, neither QA up to 5 mM nor trans-ACPD had a significant toxic effect in either KCl group."( NMDA and non-NMDA receptor-mediated excitotoxicity are potentiated in cultured striatal neurons by prior chronic depolarization.
Chen, Q; Reiner, A; Surmeier, DJ, 1999
)
0.3
" In particular, murine amacrine neurons have been known to show marked susceptibility to the toxic effects of kainate."( Involvement of NMDA-receptor in kainate-induced neurotoxicity in cultured fetal retinal neurons.
Akaike, A; Honda, Y; Kashii, S; Sasa, M; Tamura, Y; Ujihara, H; Yasuyoshi, H; Zhang, S, 2000
)
0.31
" Excitotoxicity is thought to underlie these and other toxic models of neuronal death."( NMDA but not non-NMDA excitotoxicity is mediated by Poly(ADP-ribose) polymerase.
Berliner, AR; Dawson, TM; Dawson, VL; Feldman, A; Guastella, DB; Herring, WJ; Mandir, AS; Poirier, GG; Poitras, MF; Wang, ZQ, 2000
)
0.31
" We investigated the effects of these cytokines on neuronal death caused by exposure of mouse organotypic hippocampal slice cultures to toxic concentrations of AMPA."( Modulator effects of interleukin-1beta and tumor necrosis factor-alpha on AMPA-induced excitotoxicity in mouse organotypic hippocampal slice cultures.
Bernardino, L; Jakobsen, B; Malva, JO; Oliveira, CR; Poulsen, FR; Silva, AP; Vezzani, A; Xapelli, S; Zimmer, J, 2005
)
0.33
" We show that channels with unedited GluR2 are highly toxic in cultured hippocampal neurons."( Novel toxicity of the unedited GluR2 AMPA receptor subunit dependent on surface trafficking and increased Ca2+-permeability.
Mahajan, SS; Ziff, EB, 2007
)
0.34
" The current study shows that D3 mESCs differentiate efficiently into neural cells involving a neurosphere-like state and that this system is suitable to detect adverse effects of neurodevelopmental toxicants."( Neural differentiation of mouse embryonic stem cells as a tool to assess developmental neurotoxicity in vitro.
Gulich, K; Hayess, K; Luch, A; Oelgeschläger, M; Pohl, EE; Riebeling, C; Seiler, AE; Sittner, D; Slawik, B; Visan, A, 2012
)
0.38
" Most frequently reported adverse events were nausea, dizziness, and headache."( A translational approach to evaluate the efficacy and safety of the novel AMPA receptor positive allosteric modulator org 26576 in adult attention-deficit/hyperactivity disorder.
Adler, LA; Cazorla, P; Kroon, RA; Schipper, J; Shahid, M; Stein, M; Szegedi, A; Tarazi, FI, 2012
)
0.38
"Although propofol is a widely used intravenous general anaesthetic, many studies report its toxic potential, particularly on the developing central nervous system."( Neurotoxicity of propofol on rat hypoglossal motoneurons in vitro.
Corsini, S; Ghezzi, F; Monni, L; Nistri, A, 2017
)
0.46
" Therefore, knowledge about the typical adverse events (AEs) for ASMs and other coadministered drugs (CDs) is essential for practitioners and patients."( Adverse Event Profiles of Antiseizure Medications and the Impact of Coadministration on Drug Tolerability in Adults with Epilepsy.
Knake, S; Kovac, S; Rosenow, F; Strzelczyk, A; van der Goten, M; von Podewils, F; Willems, LM; Zöllner, JP, 2023
)
0.91

Compound-Compound Interactions

ExcerptReferenceRelevance
" To advance isotope ratio analysis of an additional element, we present compound-specific (15)N/(14)N analysis of glyphosate and AMPA by a two step derivatization in combination with gas chromatography/isotope ratio mass spectrometry (GC/IRMS)."( Dual element ((15)N/(14)N, (13)C/(12)C) isotope analysis of glyphosate and AMPA by derivatization-gas chromatography isotope ratio mass spectrometry (GC/IRMS) combined with LC/IRMS.
Elsner, M; Jochmann, MA; Kujawinski, DM; Mogusu, EO; Wolbert, JB, 2015
)
0.42
" A reliable technique is needed to catheterize young animals aimed for in vivo testing combined with spinal cord electrophysiology, often limited by animal age, to facilitate pain research."( Atlanto-occipital catheterization of young rats for long-term drug delivery into the lumbar subarachnoid space combined with in vivo testing and electrophysiology in situ.
Kopach, O; Krotov, V; Voitenko, N, 2017
)
0.46

Bioavailability

ExcerptReferenceRelevance
" Together, these data support the idea that the synthesis of estrogen can be rapidly regulated in the brain, thus producing rapid changes in local estrogen bioavailability that could rapidly modify brain function with a time course similar to what has previously been described for neurotransmitters and neuromodulators."( Rapid control of brain aromatase activity by glutamatergic inputs.
Baillien, M; Ball, GF; Balthazart, J, 2006
)
0.33
" The orally bioavailable lead imidazolopiperazine confers complete causal prophylactic protection (15 milligrams/kilogram) in rodent models of malaria and shows potent in vivo blood-stage therapeutic activity."( Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
Barnes, SW; Bonamy, GM; Bopp, SE; Borboa, R; Bright, AT; Chatterjee, A; Che, J; Cohen, S; Dharia, NV; Diagana, TT; Fidock, DA; Froissard, P; Gagaring, K; Gettayacamin, M; Glynne, RJ; Gordon, P; Groessl, T; Kato, N; Kuhen, KL; Lee, MC; Mazier, D; McNamara, CW; Meister, S; Nagle, A; Nam, TG; Plouffe, DM; Richmond, W; Roland, J; Rottmann, M; Sattabongkot, J; Schultz, PG; Tuntland, T; Walker, JR; Winzeler, EA; Wu, T; Zhou, B; Zhou, Y, 2011
)
0.37
" In this study, we investigated the binding efficacy of activated carbon (AC) and calcium montmorillonite (CM) clay to decrease AMPA bioavailability from soil and AMPA translocation to plants."( Decreased bioavailability of aminomethylphosphonic acid (AMPA) in genetically modified corn with activated carbon or calcium montmorillonite clay inclusion in soil.
Hearon, SE; McDonald, TJ; Phillips, TD; Wang, M, 2021
)
0.62
" In the face of these data, one therapeutic approach is to increase BDNF bioavailability in brain."( Regulation of AMPAR trafficking in synaptic plasticity by BDNF and the impact of neurodegenerative disease.
Keifer, J, 2022
)
0.72
"Although Glyphosate-based herbicides are often marketed as environmentally friendly and easily biodegradable, its bioavailability and risks to wildlife raise significant concerns."( Glyphosate, AMPA and glufosinate in soils and earthworms in a French arable landscape.
Bertrand, C; Bretagnolle, V; Coeurdassier, M; Delhomme, O; Deschamps, M; Fritsch, C; Gaba, S; Millet, M; Nélieu, S; Pelosi, C, 2022
)
0.72

Dosage Studied

CNQX reversibly antagonized responses to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualate and kainate. It produced a parallel shift in their log dose-response curves.

ExcerptRelevanceReference
" AMOA (150 microM) produced a nearly parallel shift to the right of the dose-response curve for kainate-induced currents."( Stereoselective effects of AMOA on non-NMDA receptors expressed in Xenopus oocytes.
Hansen, JJ; Krogsgaard-Larsen, P; Miledi, R; Nielsen, B; Schousboe, A; Wahl, P, 1992
)
0.28
" Dose-response measurements revealed a rank order of sensitivity to the Glu analogues in the presence of 1 microM glycine and zero extracellular Mg2+; QA greater than AMPA greater than NMDA greater than KA."( Excitatory amino acid receptors on isolated retinal ganglion cells from the goldfish.
Fain, GL; Yazejian, B, 1992
)
0.28
" The dose-response relationships of the mutant receptors were studied after expression in Xenopus oocytes by injection of the mutant alpha 1 subunit-specific mRNA together with the wild-type alpha 2-subunit-specific mRNA."( Mutations in a putative agonist binding region of the AMPA-selective glutamate receptor channel.
Mishina, M; Nagahari, K; Sakimura, K; Uchino, S, 1992
)
0.28
" Dose-response curves obtained in oocytes were bell shaped, with a negative slope for high concentrations of QA."( Reduction of desensitization of a glutamate ionotropic receptor by antagonists.
Audinat, E; Crepel, F; Geoffroy, M; Hamon, B; Kado, RT; Lambolez, B; Rossier, J, 1991
)
0.28
", allowing for better dosage control."( 4-(Tetrazolylalkyl)piperidine-2-carboxylic acids. Potent and selective N-methyl-D-aspartic acid receptor antagonists with a short duration of action.
Arnold, MB; Elzey, T; Leander, JD; Lodge, D; Ornstein, PL; Paschal, JW; Schoepp, DD, 1991
)
0.28
" Ethanol shifted the N-methyl-D-aspartate (NMDA) dose-response curves to the right in a non-parallel manner."( Ethanol inhibition of NMDA mediated depolarizations is increased in the presence of Mg2+.
Bian, XP; Martin, D; Morrisett, RA; Swartzwelder, HS; Wilson, WA, 1991
)
0.28
" Neither drug effected seizures in control rats, however, both GDEE and MK-801 produced a leftward shift in the strychnine-seizure dose-response curve in 3AP inferior olive-lesioned rats."( The effects of inferior olive lesion on strychnine seizure.
Anderson, MC; Chung, EY; Van Woert, MH, 1990
)
0.28
" At a concentration of 10 microM, CNQX reversibly antagonized responses to alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), quisqualate and kainate; it produced a parallel shift in their log dose-response curves."( 6-Cyano-7-nitroquinoxaline-2,3-dione as an excitatory amino acid antagonist in area CA1 of rat hippocampus.
Blake, JF; Brown, MW; Collingridge, GL; Yates, RG, 1989
)
0.51
" The NMDA receptor antagonists D(-)-2-amino-5-phosphonovalerate (D-AP5), phencyclidine and Mg2+ shifted the NMDA dose-response curve to the right in a parallel manner."( A grease-gap method for studying the excitatory amino acid pharmacology of CA1 hippocampal pyramidal cells.
Bowe, MA; Martin, D; Nadler, JV, 1989
)
0.28
" Their respective dose-response curves had a similar maximum but the slope of the curve for AMPA was consistently steeper than that for quisqualate."( The pharmacology of quisqualate and AMPA in the cerebral cortex of the rat in vitro.
Horne, AL; Simmonds, MA, 1989
)
0.28
" The effect of kynurenic acid could be blocked by a nonconvulsive dosage of kainic acid."( The WAG/Rij rat model for nonconvulsive absence epilepsy: involvement of nonNMDA receptors.
Coenen, AM; Peeters, BW; Ramakers, GM; Vossen, JM, 1994
)
0.29
" After block of desensitization by concanavalin-A, dose-response analysis for activation of kainate-preferring receptors in DRG neurons gave the potency sequence trifluoromethyl > iodo > bromo approximately chloro > nitro approximately cyano > kainate > methyl > fluoro > (R,S)-AMPA >> willardiine; EC50 values for the most and least potent willardiine derivatives, 5-trifluoromethyl (70 nM) and 5-fluoro (69 microM), differed 1000-fold."( Willardiines differentiate agonist binding sites for kainate- versus AMPA-preferring glutamate receptors in DRG and hippocampal neurons.
Jane, DE; Mayer, ML; Watkins, JC; Wong, LA, 1994
)
0.29
" Dose-response curves for KA in oocytes injected with calf (EC50 = 96."( Species-dependent functional properties of non-NMDA receptors expressed in Xenopus laevis oocytes injected with mammalian and avian brain mRNA.
Bowie, D; Smart, TG, 1994
)
0.29
" Pretreatment with glycine, an agonist to the glycine/NMDA receptors, shifted the dose-response effect of felbamate to the right (ED50 = 56."( Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.
Aguglia, U; Bertorelli, R; De Sarro, A; De Sarro, G; Ongini, E, 1994
)
0.29
" In contrast, mixed and pure neuronal cultures exposed to NMDA for 10 min, or to kainate for 24 hr, had similar injury dose-response curves, suggesting that glial glutamate uptake is a less important protective mechanism in these excitotoxic injuries."( Glia modulate the response of murine cortical neurons to excitotoxicity: glia exacerbate AMPA neurotoxicity.
Amagasu, SM; Bruno, VM; Dugan, LL; Giffard, RG, 1995
)
0.29
" The dose-response curve of PS action showed significant potentiation above 250 nM and a half-maximal effect at approximately 29 microM."( Pregnenolone sulfate potentiation of N-methyl-D-aspartate receptor channels in hippocampal neurons.
Bowlby, MR, 1993
)
0.29
" Cyclothiazide increased the maximum response to a saturating concentration of kainate by approximately 300% and produced a shift to the left in the kainate dose-response curve."( Hippocampal neurons exhibit cyclothiazide-sensitive rapidly desensitizing responses to kainate.
Mayer, ML; Patneau, DK; Vyklicky, L, 1993
)
0.29
" Agonist dose-response curves were generated in the presence and absence of various concentrations of ethanol."( Ethanol inhibition of AMPA and kainate receptor-mediated depolarizations of hippocampal area CA1.
Martin, D; Swartzwelder, HS; Tayyeb, MI, 1995
)
0.29
" Initial dose-response curves revealed that dopamine was approximately equipotent at producing motor activity after microinjection into the core and shell, AMPA was more effective in the core, whereas DAMGO was more potent in the shell."( Involvement of the ventral tegmental area in locomotion elicited from the nucleus accumbens or ventral pallidum.
Churchill, L; Hooks, MS; Johnson, K; Kalivas, PW; Klitenick, MA, 1996
)
0.29
" In a third experiment the dose-response effects of central AMPA on LH secretion were examined more closely."( Photoperiod regulates the LH response to central glutamatergic stimulation in the male Syrian hamster.
Ebling, FJ; Hastings, MH; Hui, Y; Maywood, ES; Mirakhur, A, 1993
)
0.29
" CPPG produces rightward parallel shifts of the dose-response curves for both L-AP4- and (1S,3S)-ACPD, with Schild slope in each case close to unity, consistent with a competitive mechanism of antagonism."( Potent antagonists at the L-AP4- and (1S,3S)-ACPD-sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord.
Jane, DE; Thomas, NK; Tse, HW; Watkins, JC, 1996
)
0.29
" Dose-response curves obtained from glutamate activated whole cell currents yielded an IC50 value for EB of 13."( Differential modulation of AMPA receptor mediated currents by evans blue in postnatal rat hippocampal neurones.
Dietzel, ID; Lessmann, V; Schürmann, B; Wu, X, 1997
)
0.3
" YM90K induced a parallel and rightward shift of both kainate and AMPA dose-response curves."( The AMPA-receptor antagonist YM90K reduces AMPA receptor-mediated excitotoxicity in rat hippocampal cultures.
Ohno, K; Okada, M; Sakamoto, S; Tsutsumi, R; Yamaguchi, T, 1998
)
0.3
" The role of different Ca2+ channel subtypes in shaping the Ca2+ dose-response relationship was studied using the selective Ca2+ channel blockers omega-agatoxin GIVA (omega-Aga), which blocks P/Q-type channels, and omega-conotoxin GVIA (omega-CTx), which blocks N-type channels."( N- and P/Q-type Ca2+ channels mediate transmitter release with a similar cooperativity at rat hippocampal autapses.
Bekkers, JM; Clements, JD; Reid, CA, 1998
)
0.3
" Cyclothiazide produced a leftward shift of the kainate dose-response curve and enhanced the maximum response of kainate excitotoxicity."( Characterization of cyclothiazide-enhanced kainate excitotoxicity in rat hippocampal cultures.
Matsumoto, N; Ohno, K; Okada, M; Tsutsumi, R; Yamaguchi, T, 1998
)
0.3
" Morphine dose-response curves were carried out for morphine and fixed doses of ACEA 1021 (12 microg) or AP-5 (10 microg)."( Effects of intrathecal NMDA and non-NMDA antagonists on acute thermal nociception and their interaction with morphine.
Nishiyama, T; Weber, E; Yaksh, TL, 1998
)
0.3
" In a separate series of experiments, dose-response curves were measured for cells in the visual cortex in response to iontophoresis of NMDA or alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA), and the effect of an injection of MK-801 on these curves was measured."( Injection of MK-801 affects ocular dominance shifts more than visual activity.
Beaver, CJ; Czepita, D; Daw, NW; Flavin, HJ; Fox, KD; Gordon, B; Ji, Q; Kirsch, JD; Reid, SN, 1999
)
0.5
" In an attempt to further clarify the mechanisms underlying these degeneration patterns, autoradiographic studies using a variety of receptor ligands were conducted in animals 21 days after an identical dosage of the continuous phencyclidine administration employed in the previous degeneration studies."( Long-term changes in brain following continuous phencyclidine administration: an autoradiographic study using flunitrazepam, ketanserin, mazindol, quinuclidinyl benzilate, piperidyl-3,4-3H(N)-TCP, and AMPA receptor ligands.
Ellison, G; Keys, A; Noguchi, K, 1999
)
0.3
" Because of the lack of specificity of ibotenic acid for a glutamate receptor subtype, a dose-response study with alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate was undertaken and calcified areas (identified with Alizarin Red staining) as well as astro- and microglial reactions (by autoradiography with [3H]lazabemide and [3H]Ro 5-4864) were quantified at one month post-lesion."( Long-term effects of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate and 6-nitro-7-sulphamoylbenzo(f)quinoxaline-2,3-dione in the rat basal ganglia: calcification, changes in glutamate receptors and glial reactions.
Cummins, DJ; Dewar, D; Dragunow, M; Mahy, N; Petegnief, V; Saura, J, 1999
)
0.3
"In the first series of experiments, dose-response curves were generated to examine the effect of CGP56433A (0."( The GABA(B) antagonist CGP56433A attenuates the effect of baclofen on cocaine but not heroin self-administration in the rat.
Brebner, K; Froestl, W; Roberts, DC, 2002
)
0.31
" injections at 1-h intervals, the first dosage was given shortly after the intrastriatal injection of (S)-alpha-amino-3-hydroxy-5,7-methylisoxazole-4-propionic acid (AMPA) (2."( Protective effect of the antiepileptic drug candidate talampanel against AMPA-induced striatal neurotoxicity in neonatal rats.
Banczerowski-Pelyhe, I; Gulyás-Kovács, A; Takács, J; Tarnawa, I; Világi, I, 2002
)
0.31
" Glutamate depressed the GABA dose-response curve without shifting the curve laterally or altering the voltage dependence of the current."( Glutamate modulation of GABA transport in retinal horizontal cells of the skate.
Andersen, KA; Kreitzer, MA; Malchow, RP, 2003
)
0.32
" To gain more insight into retinal excitotoxicity, we carried out a dose-response study in adult rats using alpha-amino-3-hydroxy-5-methylisoxazole-4-propionic acid (AMPA), a glutamate analogue."( Low sensitivity of retina to AMPA-induced calcification.
Andrés, N; Mahy, N; Malpesa, Y; Rodríguez, MJ, 2003
)
0.32
" D-aspartate concentration-dependently shifted the dose-response curve of kainate to the right."( D-aspartate and NMDA, but not L-aspartate, block AMPA receptors in rat hippocampal neurons.
Bai, D; Frandsen, A; Gong, XQ; Lu, WY; Pickering, DS; Wan, Y; Zabek, RL, 2005
)
0.33
" All three agonists achieve micromolar concentrations measured in whole brain after dosing with 10 mg/kg SC."( Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats.
O'neill, MF; Ornstein, PL; Osborne, DJ; Sanger, G; Woodhouse, SM, 2005
)
0.33
" Dosing order was determined by a within-subject Latin square design."( Different patterns of pharmacological reinstatement of cocaine-seeking behavior between Fischer 344 and Lewis rats.
Kruzich, PJ; Xi, J, 2006
)
0.33
" AMPA dose-response curves had similar EC50 but maximal responses increased in neurons isolated from DiA-labeled CIH (20."( Chronic intermittent hypoxia alters NMDA and AMPA-evoked currents in NTS neurons receiving carotid body chemoreceptor inputs.
de Paula, PM; Mifflin, S; Tolstykh, G, 2007
)
0.34
" To investigate whether similar effects are present in the hippocampus, AMPA dose-response and calcium movement blockade were performed."( Nimodipine inhibits TMB-8 potentiation of AMPA-induced hippocampal neurodegeneration.
Bernal, F; Mahy, N; Petegnief, V; Pugliese, M; Rodríguez, MJ; Ursu, G, 2009
)
0.35
" The dose-response curve to glutamate was significantly broader in the presence of the desensitization inhibitor cyclothiazide."( Pharmacological characterization, localization, and regulation of ionotropic glutamate receptors in skate horizontal cells.
Birnbaum, AD; Kreitzer, MA; Malchow, RP; Qian, H,
)
0.13
" HVs (n = 36) and patients with MDD (n = 54) were dosed under similarly controlled conditions in an inpatient facility, HVs for up to 14 days and MDD patients for up to 28 days."( Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
Bursi, R; Dogterom, P; Ereshefsky, L; Gertsik, L; Mant, T; Nations, KR; Schipper, J, 2012
)
0.38
"This article presents safety, tolerability, and pharmacokinetic data from two different populations examined under similar dosing conditions."( Maximum tolerated dose evaluation of the AMPA modulator Org 26576 in healthy volunteers and depressed patients: a summary and method analysis of bridging research in support of phase II dose selection.
Bursi, R; Dogterom, P; Ereshefsky, L; Gertsik, L; Mant, T; Nations, KR; Schipper, J, 2012
)
0.38
" Part I (N=24) evaluated the maximum tolerated dose (MTD) and optimal titration schedule in a multiple rising dose paradigm (range 100 mg BID to 600 mg BID); Part II (N=30) utilized a parallel groups design (100 mg BID, 400 mg BID, placebo) to examine all endpoints over a 28-day dosing period."( Examination of Org 26576, an AMPA receptor positive allosteric modulator, in patients diagnosed with major depressive disorder: an exploratory, randomized, double-blind, placebo-controlled trial.
Bursi, R; Dogterom, P; Ereshefsky, L; Gertsik, L; Greenwald, S; Johnstone, J; Lee, A; Nations, KR; Pande, Y; Ruigt, G; Schipper, J; Zraket, D, 2012
)
0.38
"Agonistic profiles of AMPA receptor (AMPA-R) potentiators may be associated with seizure risk and bell-shaped dose-response effects."( Strictly regulated agonist-dependent activation of AMPA-R is the key characteristic of TAK-653 for robust synaptic responses and cognitive improvement.
Awasaki, Y; Kaku, T; Kimura, H; Kosugi, Y; Kuno, H; Kunugi, A; Sogabe, S; Suzuki, A; Suzuki, M; Suzuki, N; Tajima, Y; Toyofuku, M, 2021
)
0.62
" However, almost all known AMPA-R potentiators carry the risk of a narrow bell-shaped dose-response curve and a poor safety margin against seizures."( Role of the AMPA receptor in antidepressant effects of ketamine and potential of AMPA receptor potentiators as a novel antidepressant.
Hara, H; Kimura, H; Suzuki, A, 2023
)
0.91
" We observed a dose-response relationship between consumption of whole grain bread and higher urinary glyphosate concentrations."( Urinary concentrations and determinants of glyphosate and glufosinate in pregnant Canadian participants in the MIREC study.
Arbuckle, TE; Ashley-Martin, J; Bienvenu, JF; Borghese, MM; Bouchard, MF; Brion, O; Fisher, M; Foster, WG; Gaudreau, E; Huang, R; Lanphear, B; MacPherson, S; Owen, J, 2023
)
0.91
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
non-proteinogenic alpha-amino acidAny alpha-amino acid which is not a member of the group of 23 proteinogenic amino acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (70)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
phosphopantetheinyl transferaseBacillus subtilisPotency76.51720.141337.9142100.0000AID1490
USP1 protein, partialHomo sapiens (human)Potency44.66840.031637.5844354.8130AID504865
Microtubule-associated protein tauHomo sapiens (human)Potency3.16230.180013.557439.8107AID1460
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency44.66840.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency0.01000.001318.074339.8107AID926
cytochrome P450 2D6 isoform 1Homo sapiens (human)Potency15.84890.00207.533739.8107AID891
cytochrome P450 2C19 precursorHomo sapiens (human)Potency2.51190.00255.840031.6228AID899
cytochrome P450 2C9 precursorHomo sapiens (human)Potency10.00000.00636.904339.8107AID883
muscarinic acetylcholine receptor M1Rattus norvegicus (Norway rat)Potency28.18380.00106.000935.4813AID943
Histamine H2 receptorCavia porcellus (domestic guinea pig)Potency10.00000.00638.235039.8107AID883
arylsulfatase AHomo sapiens (human)Potency0.00541.069113.955137.9330AID720538
euchromatic histone-lysine N-methyltransferase 2Homo sapiens (human)Potency21.19230.035520.977089.1251AID504332
chromobox protein homolog 1Homo sapiens (human)Potency50.11870.006026.168889.1251AID488953
flap endonuclease 1Homo sapiens (human)Potency8.43680.133725.412989.1251AID588795
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Inhibition Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Cytochrome P450 1A2Homo sapiens (human)Ki0.02200.00561.15349.0000AID541687
Cytochrome P450 3A4Homo sapiens (human)Ki0.02200.00011.41629.9000AID541687
Glutamate receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)0.10490.00011.617910.0000AID31586; AID92198; AID92212; AID92354; AID92499; AID92501; AID92505
Glutamate receptor 1Rattus norvegicus (Norway rat)Ki0.02200.00000.41052.7800AID1553738; AID541687
Glutamate receptor 2Rattus norvegicus (Norway rat)IC50 (µMol)0.10490.00011.700010.0000AID31586; AID92198; AID92212; AID92354; AID92499; AID92501; AID92505
Glutamate receptor 2Rattus norvegicus (Norway rat)Ki0.01700.00000.68536.3000AID1553739; AID541688
Glutamate receptor 3Rattus norvegicus (Norway rat)IC50 (µMol)0.10490.00011.700010.0000AID31586; AID92198; AID92212; AID92354; AID92499; AID92501; AID92505
Glutamate receptor 3Rattus norvegicus (Norway rat)Ki0.02100.00000.71777.4000AID1553740; AID541689
Glutamate receptor 4Rattus norvegicus (Norway rat)IC50 (µMol)0.10490.00011.700010.0000AID31586; AID92198; AID92212; AID92354; AID92499; AID92501; AID92505
Glutamate receptor 4Rattus norvegicus (Norway rat)Ki0.04000.00000.52773.5700AID1553741; AID541690
Cytochrome P450 2B6Homo sapiens (human)Ki0.02180.00041.416010.0000AID541687; AID541689
Cytochrome P450 3A5Homo sapiens (human)Ki0.02200.02202.60407.6000AID541687
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00700.98217.0000AID93117; AID93558; AID93570; AID93720; AID93725
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)Ki1.15000.00071.71758.1800AID541691
Cytochrome P450 3A7Homo sapiens (human)Ki0.02200.02205.07407.6000AID541687
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.600310.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)Ki100.00000.00030.86666.6900AID538680
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)Ki1.15000.00071.75084.8000AID239055
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00701.01327.0000AID93117; AID93558; AID93570; AID93720; AID93725
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)Ki1,000.00000.00370.80254.1000AID541692
Glutamate receptor 1Homo sapiens (human)Ki0.06250.01472.50379.2000AID239015; AID92951
Glutamate receptor 2Homo sapiens (human)Ki0.06190.01681.27725.0000AID239016; AID92962
Glutamate receptor 3Homo sapiens (human)Ki0.02060.02060.53222.2000AID239017
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00701.01327.0000AID93117; AID93558; AID93570; AID93720; AID93725
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)Ki42.70000.00380.79754.1000AID541693
Glutamate receptor 4Homo sapiens (human)Ki0.09750.04001.23358.8500AID239018; AID93111
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.630610.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)Ki100.00000.00030.68056.6900AID538680
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00061.525710.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)Ki100.00000.00030.70716.6900AID538680
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.747210.0000AID143459; AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)Ki100.00000.00030.81966.6900AID538680
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00701.01327.0000AID93117; AID93558; AID93570; AID93720; AID93725
Glutamate carboxypeptidase 2Homo sapiens (human)IC50 (µMol)10,000.00000.00030.83169.5000AID1797641
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)Ki1,000.00000.00120.33441.1060AID239056
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)Ki2.14400.00800.71552.1440AID93254
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID538680
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00701.01327.0000AID93117; AID93558; AID93570; AID93720; AID93725
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID538680
Cytochrome P450 3A43 Homo sapiens (human)Ki0.02200.02205.07407.6000AID541687
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID144470; AID144607; AID144902; AID144993; AID145036
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID538680
Glutamate receptor ionotropic, NMDA 2DHomo sapiens (human)IC50 (µMol)100.00000.00401.73519.8000AID143450
Glutamate receptor ionotropic, NMDA 3BHomo sapiens (human)IC50 (µMol)100.00000.00401.65799.8000AID143450
Integrin beta-3Homo sapiens (human)IC50 (µMol)100.00000.00010.632310.0000AID92051
Integrin alpha-IIbHomo sapiens (human)IC50 (µMol)100.00000.00010.730910.0000AID92051
Glutamate receptor 1Rattus norvegicus (Norway rat)IC50 (µMol)12.63740.00011.617910.0000AID31459; AID92051; AID92342; AID92344; AID92365; AID92368; AID92501; AID92944
Glutamate receptor 1Rattus norvegicus (Norway rat)Ki0.01100.00000.41052.7800AID286976; AID391442
Glutamate receptor 2Rattus norvegicus (Norway rat)IC50 (µMol)14.43700.00011.700010.0000AID31459; AID92051; AID92342; AID92344; AID92365; AID92368; AID92501
Glutamate receptor 2Rattus norvegicus (Norway rat)Ki0.00840.00000.68536.3000AID286977; AID391443
Glutamate receptor 3Rattus norvegicus (Norway rat)IC50 (µMol)14.43700.00011.700010.0000AID31459; AID92051; AID92342; AID92344; AID92365; AID92368; AID92501
Glutamate receptor 3Rattus norvegicus (Norway rat)Ki0.01030.00000.71777.4000AID286978; AID391444
Glutamate receptor 4Rattus norvegicus (Norway rat)IC50 (µMol)14.43700.00011.700010.0000AID31459; AID92051; AID92342; AID92344; AID92365; AID92368; AID92501
Glutamate receptor 4Rattus norvegicus (Norway rat)Ki0.02000.00000.52773.5700AID286979; AID391445
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)IC50 (µMol)80.04000.00700.98217.0000AID93116; AID93564; AID93712; AID95528
Glutamate receptor ionotropic, kainate 1Rattus norvegicus (Norway rat)Ki0.57560.00071.71758.1800AID286980; AID391446
Glutamate receptor 1Mus musculus (house mouse)IC50 (µMol)0.04000.04000.75502.3000AID92048
Glutamate receptor 2Mus musculus (house mouse)IC50 (µMol)0.04000.04000.75502.3000AID92048
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.600310.0000AID143152; AID144758; AID144759; AID144838; AID144839; AID145264
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)Ki100.00000.00030.86666.6900AID478464
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)IC50 (µMol)68.00000.07702.64425.0000AID91459
Glutamate receptor ionotropic, kainate 1Homo sapiens (human)Ki0.74000.00071.75084.8000AID93257
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)IC50 (µMol)80.04000.00701.01327.0000AID93116; AID93564; AID93712; AID95528
Glutamate receptor ionotropic, kainate 2Rattus norvegicus (Norway rat)Ki500.50000.00370.80254.1000AID286981; AID391447
Glutamate receptor 1Homo sapiens (human)IC50 (µMol)0.13530.01901.70836.5100AID92806; AID92807; AID92930
Glutamate receptor 1Homo sapiens (human)Ki0.02200.01472.50379.2000AID92959
Glutamate receptor 2Homo sapiens (human)IC50 (µMol)0.13530.01901.64035.5000AID92806; AID92807; AID92930
Glutamate receptor 2Homo sapiens (human)Ki0.01700.01681.27725.0000AID93098
Glutamate receptor 3Homo sapiens (human)IC50 (µMol)0.13530.01901.13424.8000AID92806; AID92807; AID92930
Glutamate receptor 3Homo sapiens (human)Ki0.02100.02060.53222.2000AID93106
Glutamate receptor ionotropic, kainate 3Rattus norvegicus (Norway rat)IC50 (µMol)83.36670.00701.01327.0000AID93116; AID93126; AID93564; AID93712; AID95528
Excitatory amino acid transporter 1Homo sapiens (human)IC50 (µMol)1,000.00000.120089.38251,000.0000AID71159
Excitatory amino acid transporter 2Homo sapiens (human)IC50 (µMol)1,000.00000.95504.465411.0000AID71161
Excitatory amino acid transporter 3Homo sapiens (human)IC50 (µMol)1,000.00000.800015.9060161.0000AID71163
Glutamate receptor 4Homo sapiens (human)IC50 (µMol)0.13530.01901.22234.8000AID92806; AID92807; AID92930
Glutamate receptor 4Homo sapiens (human)Ki0.04000.04001.23358.8500AID93115
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.630610.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)Ki100.00000.00030.68056.6900AID478464
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00061.525710.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)Ki100.00000.00030.70716.6900AID478464
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.747210.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)Ki100.00000.00030.81966.6900AID143462; AID478464
Glutamate receptor ionotropic, kainate 4Rattus norvegicus (Norway rat)IC50 (µMol)80.04000.00701.01327.0000AID93116; AID93564; AID93712; AID95528
Glutamate receptor ionotropic, NMDA 1Homo sapiens (human)IC50 (µMol)100.00000.00101.88779.8000AID143450
Glutamate receptor ionotropic, NMDA 2AHomo sapiens (human)IC50 (µMol)100.00000.00101.99589.8000AID143450
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)IC50 (µMol)68.00000.07700.07700.0770AID91459
Glutamate receptor ionotropic, kainate 2Homo sapiens (human)Ki100.00000.00120.33441.1060AID93406
Glutamate receptor ionotropic, kainate 3Homo sapiens (human)IC50 (µMol)68.00000.07702.03854.0000AID91459
Glutamate receptor ionotropic, NMDA 2BHomo sapiens (human)IC50 (µMol)100.00000.00401.33259.8000AID143450
Glutamate receptor ionotropic, NMDA 2CHomo sapiens (human)IC50 (µMol)100.00000.00401.86339.8000AID143450
Glutamate receptor ionotropic, kainate 4Homo sapiens (human)IC50 (µMol)68.00000.07700.07700.0770AID91459
Glutamate receptor ionotropic, kainate 5Homo sapiens (human)IC50 (µMol)68.00000.07700.07700.0770AID91459
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID478464
Glutamate receptor ionotropic, kainate 5Rattus norvegicus (Norway rat)IC50 (µMol)80.04000.00701.01327.0000AID93116; AID93564; AID93712; AID95528
Glutamate receptor ionotropic, NMDA 3AHomo sapiens (human)IC50 (µMol)100.00000.00401.65799.8000AID143450
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID478464
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)IC50 (µMol)100.00000.00071.741110.0000AID143152; AID144758; AID144759; AID144838; AID144839
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)Ki100.00000.00030.70726.6900AID478464
Glutamate receptor 4Mus musculus (house mouse)IC50 (µMol)0.04000.04000.75502.3000AID92048
Glutamate receptor 3Mus musculus (house mouse)IC50 (µMol)0.04000.04000.75502.3000AID92048
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Activation Measurements

ProteinTaxonomyMeasurementAverageMin (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, Glutamate Receptor Subunit 2Rattus norvegicus (Norway rat)Kd0.02480.02480.02480.0248AID977611
Chain A, Glutamate receptor 2Rattus norvegicus (Norway rat)Kd12.80000.16004.900012.8000AID977611
Chain A, Glutamate receptor 2Rattus norvegicus (Norway rat)Kd12.80000.16004.900012.8000AID977611
Chain C, Glutamate receptor 2Rattus norvegicus (Norway rat)Kd12.80000.16004.900012.8000AID977611
Metabotropic glutamate receptor 6Homo sapiens (human)EC50 (µMol)220.00000.05502.27864.9000AID107254
Glutamate receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)3.50000.00411.89638.7000AID92195; AID92794
Glutamate receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)3.50000.00411.62517.6000AID92195; AID92794
Glutamate receptor 3Rattus norvegicus (Norway rat)EC50 (µMol)3.50000.00411.17063.5000AID92195; AID92794
Glutamate receptor 4Rattus norvegicus (Norway rat)EC50 (µMol)3.50000.00411.13393.5000AID92195; AID92794
Glutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)EC50 (µMol)51.75000.00301.29038.3000AID144319; AID144826
Glutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)EC50 (µMol)51.75000.00301.02226.8600AID144319; AID144826
Glutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)EC50 (µMol)51.75000.00300.86696.8600AID144319; AID144826
Glutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)EC50 (µMol)51.75000.00301.11276.8600AID144319; AID144826
Metabotropic glutamate receptor 1Homo sapiens (human)EC50 (µMol)1,000.00000.20004.41009.3000AID108656
Metabotropic glutamate receptor 2Homo sapiens (human)EC50 (µMol)1,000.00000.00061.17848.5000AID109010
Metabotropic glutamate receptor 4Homo sapiens (human)EC50 (µMol)3,000.00000.00401.71939.8000AID109481
Glutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)EC50 (µMol)51.75000.00301.39378.3000AID144319; AID144826
Glutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)EC50 (µMol)51.75000.00300.90516.8600AID144319; AID144826
Glutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)EC50 (µMol)51.75000.00300.90516.8600AID144319; AID144826
Glutamate receptor 1Rattus norvegicus (Norway rat)EC50 (µMol)21.73330.00411.89638.7000AID31454; AID477117; AID477138
Glutamate receptor 2Rattus norvegicus (Norway rat)EC50 (µMol)35.25000.00411.62517.6000AID31454; AID477139
Glutamate receptor 3Rattus norvegicus (Norway rat)EC50 (µMol)10.82500.00411.17063.5000AID31454; AID477118; AID477140; AID93103
Glutamate receptor 4Rattus norvegicus (Norway rat)EC50 (µMol)9.75000.00411.13393.5000AID31454; AID477141
Glutamate receptor 1Mus musculus (house mouse)EC50 (µMol)8.70008.70008.70008.7000AID92955
Glutamate receptor 1Homo sapiens (human)EC50 (µMol)3.31000.38004.113810.0000AID477146
Glutamate receptor 2Homo sapiens (human)EC50 (µMol)3.31000.15003.05607.6000AID477146
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (302)

Processvia Protein(s)Taxonomy
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 6Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 6Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 6Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 6Homo sapiens (human)
detection of visible lightMetabotropic glutamate receptor 6Homo sapiens (human)
detection of light stimulus involved in visual perceptionMetabotropic glutamate receptor 6Homo sapiens (human)
retina development in camera-type eyeMetabotropic glutamate receptor 6Homo sapiens (human)
positive regulation of calcium ion import across plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 6Homo sapiens (human)
steroid catabolic processCytochrome P450 1A2Homo sapiens (human)
porphyrin-containing compound metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 1A2Homo sapiens (human)
cholesterol metabolic processCytochrome P450 1A2Homo sapiens (human)
estrogen metabolic processCytochrome P450 1A2Homo sapiens (human)
toxin biosynthetic processCytochrome P450 1A2Homo sapiens (human)
post-embryonic developmentCytochrome P450 1A2Homo sapiens (human)
alkaloid metabolic processCytochrome P450 1A2Homo sapiens (human)
regulation of gene expressionCytochrome P450 1A2Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 1A2Homo sapiens (human)
dibenzo-p-dioxin metabolic processCytochrome P450 1A2Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lung developmentCytochrome P450 1A2Homo sapiens (human)
methylationCytochrome P450 1A2Homo sapiens (human)
monocarboxylic acid metabolic processCytochrome P450 1A2Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 1A2Homo sapiens (human)
retinol metabolic processCytochrome P450 1A2Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 1A2Homo sapiens (human)
cellular respirationCytochrome P450 1A2Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 1A2Homo sapiens (human)
hydrogen peroxide biosynthetic processCytochrome P450 1A2Homo sapiens (human)
oxidative demethylationCytochrome P450 1A2Homo sapiens (human)
cellular response to cadmium ionCytochrome P450 1A2Homo sapiens (human)
omega-hydroxylase P450 pathwayCytochrome P450 1A2Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A4Homo sapiens (human)
lipid metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid catabolic processCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A4Homo sapiens (human)
steroid metabolic processCytochrome P450 3A4Homo sapiens (human)
cholesterol metabolic processCytochrome P450 3A4Homo sapiens (human)
androgen metabolic processCytochrome P450 3A4Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A4Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A4Homo sapiens (human)
monoterpenoid metabolic processCytochrome P450 3A4Homo sapiens (human)
calcitriol biosynthetic process from calciolCytochrome P450 3A4Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D metabolic processCytochrome P450 3A4Homo sapiens (human)
vitamin D catabolic processCytochrome P450 3A4Homo sapiens (human)
retinol metabolic processCytochrome P450 3A4Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A4Homo sapiens (human)
long-chain fatty acid biosynthetic processCytochrome P450 3A4Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A4Homo sapiens (human)
oxidative demethylationCytochrome P450 3A4Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 2B6Homo sapiens (human)
steroid metabolic processCytochrome P450 2B6Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 2B6Homo sapiens (human)
cellular ketone metabolic processCytochrome P450 2B6Homo sapiens (human)
epoxygenase P450 pathwayCytochrome P450 2B6Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A5Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A5Homo sapiens (human)
steroid metabolic processCytochrome P450 3A5Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A5Homo sapiens (human)
alkaloid catabolic processCytochrome P450 3A5Homo sapiens (human)
xenobiotic catabolic processCytochrome P450 3A5Homo sapiens (human)
retinol metabolic processCytochrome P450 3A5Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A5Homo sapiens (human)
aflatoxin metabolic processCytochrome P450 3A5Homo sapiens (human)
oxidative demethylationCytochrome P450 3A5Homo sapiens (human)
lipid hydroxylationCytochrome P450 3A7Homo sapiens (human)
steroid biosynthetic processCytochrome P450 3A7Homo sapiens (human)
xenobiotic metabolic processCytochrome P450 3A7Homo sapiens (human)
steroid metabolic processCytochrome P450 3A7Homo sapiens (human)
estrogen metabolic processCytochrome P450 3A7Homo sapiens (human)
retinol metabolic processCytochrome P450 3A7Homo sapiens (human)
retinoic acid metabolic processCytochrome P450 3A7Homo sapiens (human)
oxidative demethylationCytochrome P450 3A7Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
central nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of receptor recyclingGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synapse assemblyGlutamate receptor 1Homo sapiens (human)
long-term memoryGlutamate receptor 1Homo sapiens (human)
response to xenobiotic stimulusGlutamate receptor 1Homo sapiens (human)
response to lithium ionGlutamate receptor 1Homo sapiens (human)
positive regulation of gene expressionGlutamate receptor 1Homo sapiens (human)
neuronal action potentialGlutamate receptor 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 1Homo sapiens (human)
spinal cord developmentGlutamate receptor 1Homo sapiens (human)
cerebral cortex developmentGlutamate receptor 1Homo sapiens (human)
receptor internalizationGlutamate receptor 1Homo sapiens (human)
response to estradiolGlutamate receptor 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 1Homo sapiens (human)
response to cocaineGlutamate receptor 1Homo sapiens (human)
positive regulation of membrane potentialGlutamate receptor 1Homo sapiens (human)
response to arsenic-containing substanceGlutamate receptor 1Homo sapiens (human)
response to electrical stimulusGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 1Homo sapiens (human)
long-term synaptic depressionGlutamate receptor 1Homo sapiens (human)
response to fungicideGlutamate receptor 1Homo sapiens (human)
cellular response to amino acid stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to ammonium ionGlutamate receptor 1Homo sapiens (human)
cellular response to dsRNAGlutamate receptor 1Homo sapiens (human)
cellular response to peptide hormone stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to amine stimulusGlutamate receptor 1Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
cellular response to brain-derived neurotrophic factor stimulusGlutamate receptor 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 2Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 3Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 3Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
protein homotetramerizationGlutamate receptor 3Homo sapiens (human)
protein heterotetramerizationGlutamate receptor 3Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 3Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 3Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 4Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic processGlutamate receptor 4Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 4Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 4Homo sapiens (human)
proteolysisGlutamate carboxypeptidase 2Homo sapiens (human)
folic acid-containing compound metabolic processGlutamate carboxypeptidase 2Homo sapiens (human)
C-terminal protein deglutamylationGlutamate carboxypeptidase 2Homo sapiens (human)
behavioral fear responseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
intracellular calcium ion homeostasisGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuronal action potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
receptor clusteringGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of JNK cascadeGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of long-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of short-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
inhibitory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
detection of cold stimulus involved in thermoceptionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
G protein-coupled receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
phospholipase C-activating G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 1Homo sapiens (human)
locomotory behaviorMetabotropic glutamate receptor 1Homo sapiens (human)
sensory perception of painMetabotropic glutamate receptor 1Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of sensory perception of painMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 1Homo sapiens (human)
cellular response to electrical stimulusMetabotropic glutamate receptor 1Homo sapiens (human)
L-glutamate import across plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 1Homo sapiens (human)
negative regulation of adenylate cyclase activityMetabotropic glutamate receptor 2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 2Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 2Homo sapiens (human)
gene expressionMetabotropic glutamate receptor 2Homo sapiens (human)
glutamate secretionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of glutamate secretionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of dopamine secretionMetabotropic glutamate receptor 2Homo sapiens (human)
behavioral response to nicotineMetabotropic glutamate receptor 2Homo sapiens (human)
response to cocaineMetabotropic glutamate receptor 2Homo sapiens (human)
positive regulation of phosphatidylinositol 3-kinase/protein kinase B signal transductionMetabotropic glutamate receptor 2Homo sapiens (human)
long-term synaptic depressionMetabotropic glutamate receptor 2Homo sapiens (human)
intracellular glutamate homeostasisMetabotropic glutamate receptor 2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of response to drugMetabotropic glutamate receptor 2Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 2Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 2Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 4Homo sapiens (human)
chemical synaptic transmissionMetabotropic glutamate receptor 4Homo sapiens (human)
neurotransmitter secretionMetabotropic glutamate receptor 4Homo sapiens (human)
positive regulation of MAPK cascadeMetabotropic glutamate receptor 4Homo sapiens (human)
regulation of neuron apoptotic processMetabotropic glutamate receptor 4Homo sapiens (human)
regulation of synaptic transmission, glutamatergicMetabotropic glutamate receptor 4Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayMetabotropic glutamate receptor 4Homo sapiens (human)
regulation of synaptic vesicle fusion to presynaptic active zone membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
cytochrome metabolic processCytochrome P450 3A43 Homo sapiens (human)
steroid metabolic processCytochrome P450 3A43 Homo sapiens (human)
oxidative demethylationCytochrome P450 3A43 Homo sapiens (human)
startle responseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
adult locomotory behaviorGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of sensory perception of painGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
cellular response to L-glutamateGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
protein insertion into membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of calcium ion transportGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
calcium ion transmembrane transportGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
central nervous system developmentGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
regulation of receptor recyclingGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synapse assemblyGlutamate receptor 1Homo sapiens (human)
long-term memoryGlutamate receptor 1Homo sapiens (human)
response to xenobiotic stimulusGlutamate receptor 1Homo sapiens (human)
response to lithium ionGlutamate receptor 1Homo sapiens (human)
positive regulation of gene expressionGlutamate receptor 1Homo sapiens (human)
neuronal action potentialGlutamate receptor 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 1Homo sapiens (human)
spinal cord developmentGlutamate receptor 1Homo sapiens (human)
cerebral cortex developmentGlutamate receptor 1Homo sapiens (human)
receptor internalizationGlutamate receptor 1Homo sapiens (human)
response to estradiolGlutamate receptor 1Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 1Homo sapiens (human)
response to cocaineGlutamate receptor 1Homo sapiens (human)
positive regulation of membrane potentialGlutamate receptor 1Homo sapiens (human)
response to arsenic-containing substanceGlutamate receptor 1Homo sapiens (human)
response to electrical stimulusGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 1Homo sapiens (human)
long-term synaptic depressionGlutamate receptor 1Homo sapiens (human)
response to fungicideGlutamate receptor 1Homo sapiens (human)
cellular response to amino acid stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to ammonium ionGlutamate receptor 1Homo sapiens (human)
cellular response to dsRNAGlutamate receptor 1Homo sapiens (human)
cellular response to peptide hormone stimulusGlutamate receptor 1Homo sapiens (human)
cellular response to amine stimulusGlutamate receptor 1Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
cellular response to brain-derived neurotrophic factor stimulusGlutamate receptor 1Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 1Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 1Homo sapiens (human)
signal transductionGlutamate receptor 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 2Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
calcium-mediated signalingGlutamate receptor 3Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 3Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 3Homo sapiens (human)
protein homotetramerizationGlutamate receptor 3Homo sapiens (human)
protein heterotetramerizationGlutamate receptor 3Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
long-term synaptic potentiationGlutamate receptor 3Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 3Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 3Homo sapiens (human)
neurotransmitter uptakeExcitatory amino acid transporter 1Homo sapiens (human)
monoatomic ion transportExcitatory amino acid transporter 1Homo sapiens (human)
neurotransmitter transportExcitatory amino acid transporter 1Homo sapiens (human)
intracellular sodium ion homeostasisExcitatory amino acid transporter 1Homo sapiens (human)
chemical synaptic transmissionExcitatory amino acid transporter 1Homo sapiens (human)
sensory perception of soundExcitatory amino acid transporter 1Homo sapiens (human)
response to xenobiotic stimulusExcitatory amino acid transporter 1Homo sapiens (human)
response to light stimulusExcitatory amino acid transporter 1Homo sapiens (human)
gamma-aminobutyric acid biosynthetic processExcitatory amino acid transporter 1Homo sapiens (human)
response to woundingExcitatory amino acid transporter 1Homo sapiens (human)
neutral amino acid transportExcitatory amino acid transporter 1Homo sapiens (human)
L-glutamate transmembrane transportExcitatory amino acid transporter 1Homo sapiens (human)
cranial nerve developmentExcitatory amino acid transporter 1Homo sapiens (human)
auditory behaviorExcitatory amino acid transporter 1Homo sapiens (human)
response to antibioticExcitatory amino acid transporter 1Homo sapiens (human)
cell morphogenesis involved in neuron differentiationExcitatory amino acid transporter 1Homo sapiens (human)
positive regulation of synaptic transmissionExcitatory amino acid transporter 1Homo sapiens (human)
neuromuscular process controlling balanceExcitatory amino acid transporter 1Homo sapiens (human)
L-glutamate importExcitatory amino acid transporter 1Homo sapiens (human)
transepithelial transportExcitatory amino acid transporter 1Homo sapiens (human)
D-aspartate import across plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
cellular response to cocaineExcitatory amino acid transporter 1Homo sapiens (human)
potassium ion transmembrane transportExcitatory amino acid transporter 1Homo sapiens (human)
L-glutamate import across plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
L-aspartate import across plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
transport across blood-brain barrierExcitatory amino acid transporter 1Homo sapiens (human)
chloride transmembrane transportExcitatory amino acid transporter 1Homo sapiens (human)
glutathione biosynthetic processExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic ion transportExcitatory amino acid transporter 2Homo sapiens (human)
neurotransmitter transportExcitatory amino acid transporter 2Homo sapiens (human)
chemical synaptic transmissionExcitatory amino acid transporter 2Homo sapiens (human)
visual behaviorExcitatory amino acid transporter 2Homo sapiens (human)
response to xenobiotic stimulusExcitatory amino acid transporter 2Homo sapiens (human)
response to woundingExcitatory amino acid transporter 2Homo sapiens (human)
L-glutamate transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
telencephalon developmentExcitatory amino acid transporter 2Homo sapiens (human)
adult behaviorExcitatory amino acid transporter 2Homo sapiens (human)
multicellular organism growthExcitatory amino acid transporter 2Homo sapiens (human)
response to amino acidExcitatory amino acid transporter 2Homo sapiens (human)
positive regulation of glucose importExcitatory amino acid transporter 2Homo sapiens (human)
protein homotrimerizationExcitatory amino acid transporter 2Homo sapiens (human)
transepithelial transportExcitatory amino acid transporter 2Homo sapiens (human)
L-aspartate transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
D-aspartate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
cellular response to cocaineExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic anion transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
L-glutamate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
neurotransmitter reuptakeExcitatory amino acid transporter 2Homo sapiens (human)
L-aspartate import across plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
transport across blood-brain barrierExcitatory amino acid transporter 2Homo sapiens (human)
cysteine transmembrane transportExcitatory amino acid transporter 2Homo sapiens (human)
maintenance of blood-brain barrierExcitatory amino acid transporter 3Homo sapiens (human)
blood vessel morphogenesisExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to organic cyclic compoundExcitatory amino acid transporter 3Homo sapiens (human)
behavioral fear responseExcitatory amino acid transporter 3Homo sapiens (human)
regulation of protein phosphorylationExcitatory amino acid transporter 3Homo sapiens (human)
response to amphetamineExcitatory amino acid transporter 3Homo sapiens (human)
glutathione biosynthetic processExcitatory amino acid transporter 3Homo sapiens (human)
superoxide metabolic processExcitatory amino acid transporter 3Homo sapiens (human)
monoatomic ion transportExcitatory amino acid transporter 3Homo sapiens (human)
neurotransmitter transportExcitatory amino acid transporter 3Homo sapiens (human)
intracellular zinc ion homeostasisExcitatory amino acid transporter 3Homo sapiens (human)
dopamine receptor signaling pathwayExcitatory amino acid transporter 3Homo sapiens (human)
glutamate receptor signaling pathwayExcitatory amino acid transporter 3Homo sapiens (human)
chemical synaptic transmissionExcitatory amino acid transporter 3Homo sapiens (human)
brain developmentExcitatory amino acid transporter 3Homo sapiens (human)
memoryExcitatory amino acid transporter 3Homo sapiens (human)
grooming behaviorExcitatory amino acid transporter 3Homo sapiens (human)
locomotory behaviorExcitatory amino acid transporter 3Homo sapiens (human)
response to xenobiotic stimulusExcitatory amino acid transporter 3Homo sapiens (human)
positive regulation of heart rateExcitatory amino acid transporter 3Homo sapiens (human)
gene expressionExcitatory amino acid transporter 3Homo sapiens (human)
retina layer formationExcitatory amino acid transporter 3Homo sapiens (human)
L-glutamate transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
cytokine-mediated signaling pathwayExcitatory amino acid transporter 3Homo sapiens (human)
neurogenesisExcitatory amino acid transporter 3Homo sapiens (human)
adult behaviorExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to oxidative stressExcitatory amino acid transporter 3Homo sapiens (human)
response to decreased oxygen levelsExcitatory amino acid transporter 3Homo sapiens (human)
dopamine metabolic processExcitatory amino acid transporter 3Homo sapiens (human)
cysteine transportExcitatory amino acid transporter 3Homo sapiens (human)
response to morphineExcitatory amino acid transporter 3Homo sapiens (human)
negative regulation of neuron apoptotic processExcitatory amino acid transporter 3Homo sapiens (human)
response to axon injuryExcitatory amino acid transporter 3Homo sapiens (human)
synapse organizationExcitatory amino acid transporter 3Homo sapiens (human)
L-glutamate importExcitatory amino acid transporter 3Homo sapiens (human)
righting reflexExcitatory amino acid transporter 3Homo sapiens (human)
heart contractionExcitatory amino acid transporter 3Homo sapiens (human)
long-term synaptic potentiationExcitatory amino acid transporter 3Homo sapiens (human)
motor behaviorExcitatory amino acid transporter 3Homo sapiens (human)
transepithelial transportExcitatory amino acid transporter 3Homo sapiens (human)
D-aspartate transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
L-aspartate transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
D-aspartate import across plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to ammonium ionExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to mercury ionExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to cocaineExcitatory amino acid transporter 3Homo sapiens (human)
zinc ion transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
response to anestheticExcitatory amino acid transporter 3Homo sapiens (human)
regulation of protein targeting to membraneExcitatory amino acid transporter 3Homo sapiens (human)
intracellular glutamate homeostasisExcitatory amino acid transporter 3Homo sapiens (human)
motor neuron apoptotic processExcitatory amino acid transporter 3Homo sapiens (human)
L-glutamate import across plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
neurotransmitter receptor transport to plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
postsynaptic modulation of chemical synaptic transmissionExcitatory amino acid transporter 3Homo sapiens (human)
L-aspartate import across plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
transport across blood-brain barrierExcitatory amino acid transporter 3Homo sapiens (human)
chloride transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
cysteine transmembrane transportExcitatory amino acid transporter 3Homo sapiens (human)
cellular response to bisphenol AExcitatory amino acid transporter 3Homo sapiens (human)
conditioned place preferenceExcitatory amino acid transporter 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor 4Homo sapiens (human)
negative regulation of smooth muscle cell apoptotic processGlutamate receptor 4Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor 4Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor 4Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor 4Homo sapiens (human)
cellular response to amyloid-betaGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
visual learningGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of calcium ion transport into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
propylene metabolic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of transcription by RNA polymerase IIGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion homeostasisGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of reactive oxygen species biosynthetic processGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
response to glycineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cellular response to amyloid-betaGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
startle responseGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to amphetamineGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
learning or memoryGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
memoryGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
visual learningGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to xenobiotic stimulusGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to woundingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
sensory perception of painGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
neurogenesisGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein catabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
sleepGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
directional locomotionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
negative regulation of protein catabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
dopamine metabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
serotonin metabolic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of apoptotic processGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
activation of cysteine-type endopeptidase activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein localization to postsynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
behavioral fear responseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
intracellular calcium ion homeostasisGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuronal action potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
receptor clusteringGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of JNK cascadeGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of long-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of short-term neuronal synaptic plasticityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
positive regulation of synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
neuron apoptotic processGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
inhibitory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
modulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
detection of cold stimulus involved in thermoceptionGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
adenylate cyclase-inhibiting G protein-coupled glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
G protein-coupled glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
negative regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
learning or memoryGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein heterotetramerizationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
negative regulation of dendritic spine maintenanceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
positive regulation of cysteine-type endopeptidase activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
brain developmentGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
response to woundingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
calcium-mediated signalingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
directional locomotionGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
negative regulation of protein catabolic processGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of synaptic plasticityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of neuronal synaptic plasticityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
neuromuscular process controlling balanceGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
positive regulation of synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
calcium ion transmembrane import into cytosolGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
excitatory chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
protein localization to postsynaptic membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
regulation of monoatomic cation transmembrane transportGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
positive regulation of excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
long-term synaptic potentiationGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
chemical synaptic transmissionGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
regulation of synaptic vesicle fusion to presynaptic active zone membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
monoatomic ion transmembrane transportGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
excitatory postsynaptic potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
calcium ion transportGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
dendrite developmentGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
response to ethanolGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
rhythmic processGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
prepulse inhibitionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
negative regulation of dendritic spine developmentGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
calcium ion transmembrane transportGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
presynaptic modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
ionotropic glutamate receptor signaling pathwayGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
synaptic transmission, glutamatergicGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
modulation of chemical synaptic transmissionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (113)

Processvia Protein(s)Taxonomy
G protein-coupled receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 6Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
protein homodimerization activityMetabotropic glutamate receptor 6Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 6Homo sapiens (human)
monooxygenase activityCytochrome P450 1A2Homo sapiens (human)
iron ion bindingCytochrome P450 1A2Homo sapiens (human)
protein bindingCytochrome P450 1A2Homo sapiens (human)
electron transfer activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activityCytochrome P450 1A2Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 1A2Homo sapiens (human)
enzyme bindingCytochrome P450 1A2Homo sapiens (human)
heme bindingCytochrome P450 1A2Homo sapiens (human)
demethylase activityCytochrome P450 1A2Homo sapiens (human)
caffeine oxidase activityCytochrome P450 1A2Homo sapiens (human)
aromatase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 1A2Homo sapiens (human)
hydroperoxy icosatetraenoate dehydratase activityCytochrome P450 1A2Homo sapiens (human)
monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
steroid bindingCytochrome P450 3A4Homo sapiens (human)
iron ion bindingCytochrome P450 3A4Homo sapiens (human)
protein bindingCytochrome P450 3A4Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A4Homo sapiens (human)
oxygen bindingCytochrome P450 3A4Homo sapiens (human)
enzyme bindingCytochrome P450 3A4Homo sapiens (human)
heme bindingCytochrome P450 3A4Homo sapiens (human)
vitamin D3 25-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
caffeine oxidase activityCytochrome P450 3A4Homo sapiens (human)
quinine 3-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1-alpha,25-dihydroxyvitamin D3 23-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 3A4Homo sapiens (human)
aromatase activityCytochrome P450 3A4Homo sapiens (human)
vitamin D 24-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A4Homo sapiens (human)
1,8-cineole 2-exo-monooxygenase activityCytochrome P450 3A4Homo sapiens (human)
monooxygenase activityCytochrome P450 2B6Homo sapiens (human)
iron ion bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-alpha-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
heme bindingCytochrome P450 2B6Homo sapiens (human)
testosterone 16-beta-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 8,9 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 11,12 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
anandamide 14,15 epoxidase activityCytochrome P450 2B6Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 2B6Homo sapiens (human)
oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygenCytochrome P450 2B6Homo sapiens (human)
arachidonic acid epoxygenase activityCytochrome P450 2B6Homo sapiens (human)
monooxygenase activityCytochrome P450 3A5Homo sapiens (human)
iron ion bindingCytochrome P450 3A5Homo sapiens (human)
protein bindingCytochrome P450 3A5Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
oxidoreductase activityCytochrome P450 3A5Homo sapiens (human)
oxygen bindingCytochrome P450 3A5Homo sapiens (human)
heme bindingCytochrome P450 3A5Homo sapiens (human)
aromatase activityCytochrome P450 3A5Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A5Homo sapiens (human)
monooxygenase activityCytochrome P450 3A7Homo sapiens (human)
iron ion bindingCytochrome P450 3A7Homo sapiens (human)
steroid hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
retinoic acid 4-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
oxygen bindingCytochrome P450 3A7Homo sapiens (human)
heme bindingCytochrome P450 3A7Homo sapiens (human)
all-trans retinoic acid 18-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
aromatase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
estrogen 2-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A7Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 1Homo sapiens (human)
G-protein alpha-subunit bindingGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
protein bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
adenylate cyclase bindingGlutamate receptor 1Homo sapiens (human)
immunoglobulin bindingGlutamate receptor 1Homo sapiens (human)
protein kinase bindingGlutamate receptor 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 1Homo sapiens (human)
PDZ domain bindingGlutamate receptor 1Homo sapiens (human)
small GTPase bindingGlutamate receptor 1Homo sapiens (human)
myosin V bindingGlutamate receptor 1Homo sapiens (human)
G-protein beta-subunit bindingGlutamate receptor 1Homo sapiens (human)
beta-2 adrenergic receptor bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor bindingGlutamate receptor 1Homo sapiens (human)
identical protein bindingGlutamate receptor 1Homo sapiens (human)
protein kinase A bindingGlutamate receptor 1Homo sapiens (human)
scaffold protein bindingGlutamate receptor 1Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
protein bindingGlutamate receptor 2Homo sapiens (human)
ligand-gated monoatomic cation channel activityGlutamate receptor 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 3Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 3Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 3Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 4Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
metallocarboxypeptidase activityGlutamate carboxypeptidase 2Homo sapiens (human)
peptidase activityGlutamate carboxypeptidase 2Homo sapiens (human)
dipeptidase activityGlutamate carboxypeptidase 2Homo sapiens (human)
metal ion bindingGlutamate carboxypeptidase 2Homo sapiens (human)
Ac-Asp-Glu bindingGlutamate carboxypeptidase 2Homo sapiens (human)
tetrahydrofolyl-poly(glutamate) polymer bindingGlutamate carboxypeptidase 2Homo sapiens (human)
carboxypeptidase activityGlutamate carboxypeptidase 2Homo sapiens (human)
SNARE bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
extracellularly glutamate-gated ion channel activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
PDZ domain bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin conjugating enzyme bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin protein ligase bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
identical protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
scaffold protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 1Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 1Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor activity involved in regulation of postsynaptic membrane potentialMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
calcium channel regulator activityMetabotropic glutamate receptor 2Homo sapiens (human)
protein bindingMetabotropic glutamate receptor 2Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
scaffold protein bindingMetabotropic glutamate receptor 2Homo sapiens (human)
group II metabotropic glutamate receptor activityMetabotropic glutamate receptor 2Homo sapiens (human)
G protein-coupled receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
glutamate receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityMetabotropic glutamate receptor 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
monooxygenase activityCytochrome P450 3A43 Homo sapiens (human)
iron ion bindingCytochrome P450 3A43 Homo sapiens (human)
heme bindingCytochrome P450 3A43 Homo sapiens (human)
aromatase activityCytochrome P450 3A43 Homo sapiens (human)
testosterone 6-beta-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
estrogen 16-alpha-hydroxylase activityCytochrome P450 3A43 Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
voltage-gated monoatomic cation channel activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
monoatomic cation channel activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
neurotransmitter receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 1Homo sapiens (human)
G-protein alpha-subunit bindingGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
protein bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor activityGlutamate receptor 1Homo sapiens (human)
adenylate cyclase bindingGlutamate receptor 1Homo sapiens (human)
immunoglobulin bindingGlutamate receptor 1Homo sapiens (human)
protein kinase bindingGlutamate receptor 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 1Homo sapiens (human)
PDZ domain bindingGlutamate receptor 1Homo sapiens (human)
small GTPase bindingGlutamate receptor 1Homo sapiens (human)
myosin V bindingGlutamate receptor 1Homo sapiens (human)
G-protein beta-subunit bindingGlutamate receptor 1Homo sapiens (human)
beta-2 adrenergic receptor bindingGlutamate receptor 1Homo sapiens (human)
glutamate receptor bindingGlutamate receptor 1Homo sapiens (human)
identical protein bindingGlutamate receptor 1Homo sapiens (human)
protein kinase A bindingGlutamate receptor 1Homo sapiens (human)
scaffold protein bindingGlutamate receptor 1Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 1Homo sapiens (human)
neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentrationGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 2Homo sapiens (human)
protein bindingGlutamate receptor 2Homo sapiens (human)
ligand-gated monoatomic cation channel activityGlutamate receptor 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 2Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 3Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 3Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor 3Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 3Homo sapiens (human)
L-glutamate transmembrane transporter activityExcitatory amino acid transporter 1Homo sapiens (human)
high-affinity L-glutamate transmembrane transporter activityExcitatory amino acid transporter 1Homo sapiens (human)
protein bindingExcitatory amino acid transporter 1Homo sapiens (human)
glutamate:sodium symporter activityExcitatory amino acid transporter 1Homo sapiens (human)
glutamate bindingExcitatory amino acid transporter 1Homo sapiens (human)
metal ion bindingExcitatory amino acid transporter 1Homo sapiens (human)
neutral L-amino acid transmembrane transporter activityExcitatory amino acid transporter 1Homo sapiens (human)
L-glutamate transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
high-affinity L-glutamate transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
protein bindingExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic anion transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
glutamate:sodium symporter activityExcitatory amino acid transporter 2Homo sapiens (human)
cysteine transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
metal ion bindingExcitatory amino acid transporter 2Homo sapiens (human)
neutral L-amino acid transmembrane transporter activityExcitatory amino acid transporter 2Homo sapiens (human)
monoatomic anion channel activityExcitatory amino acid transporter 3Homo sapiens (human)
L-glutamate transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
high-affinity L-glutamate transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
protein bindingExcitatory amino acid transporter 3Homo sapiens (human)
chloride transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
L-aspartate transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
glutamate:sodium symporter activityExcitatory amino acid transporter 3Homo sapiens (human)
glutamate bindingExcitatory amino acid transporter 3Homo sapiens (human)
cysteine transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
identical protein bindingExcitatory amino acid transporter 3Homo sapiens (human)
metal ion bindingExcitatory amino acid transporter 3Homo sapiens (human)
D-aspartate transmembrane transporter activityExcitatory amino acid transporter 3Homo sapiens (human)
amyloid-beta bindingGlutamate receptor 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor activityGlutamate receptor 4Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor 4Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calcium ion bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
calmodulin bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
protein-containing complex bindingGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
signaling receptor activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
ligand-gated monoatomic ion channel activityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
zinc ion bindingGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
SNARE bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
extracellularly glutamate-gated ion channel activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
PDZ domain bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin conjugating enzyme bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ubiquitin protein ligase bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
identical protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
scaffold protein bindingGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
adenylate cyclase inhibiting G protein-coupled glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
amyloid-beta bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
zinc ion bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate bindingGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamate-gated calcium ion channel activityGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
glutamate-gated receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor activityGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
ligand-gated monoatomic ion channel activity involved in regulation of presynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
NMDA glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
calcium channel activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
protein bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glycine bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
identical protein bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
protein phosphatase 2A bindingGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glutamate receptor activityGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
transmitter-gated monoatomic ion channel activity involved in regulation of postsynaptic membrane potentialGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
protein bindingGlutamate receptor 4Mus musculus (house mouse)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (103)

Processvia Protein(s)Taxonomy
Golgi membraneMetabotropic glutamate receptor 6Homo sapiens (human)
endoplasmic reticulum membraneMetabotropic glutamate receptor 6Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
dendriteMetabotropic glutamate receptor 6Homo sapiens (human)
new growing cell tipMetabotropic glutamate receptor 6Homo sapiens (human)
synapseMetabotropic glutamate receptor 6Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 1A2Homo sapiens (human)
cytoplasmCytochrome P450 3A4Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A4Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A4Homo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneCytochrome P450 2B6Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 2B6Homo sapiens (human)
cytoplasmCytochrome P450 2B6Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A5Homo sapiens (human)
intracellular membrane-bounded organelleCytochrome P450 3A5Homo sapiens (human)
endoplasmic reticulum membraneCytochrome P450 3A7Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
intracellular membrane-bounded organelleGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
cell-cell junctionGlutamate receptor 1Homo sapiens (human)
cell surfaceGlutamate receptor 1Homo sapiens (human)
ER to Golgi transport vesicle membraneGlutamate receptor 1Homo sapiens (human)
postsynaptic densityGlutamate receptor 1Homo sapiens (human)
dendriteGlutamate receptor 1Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 1Homo sapiens (human)
synaptic vesicle membraneGlutamate receptor 1Homo sapiens (human)
neuromuscular junctionGlutamate receptor 1Homo sapiens (human)
early endosome membraneGlutamate receptor 1Homo sapiens (human)
dendritic spine membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell body membraneGlutamate receptor 1Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartment membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell bodyGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
dendritic shaftGlutamate receptor 1Homo sapiens (human)
axonal spineGlutamate receptor 1Homo sapiens (human)
neuron spineGlutamate receptor 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor 1Homo sapiens (human)
presynaptic active zone membraneGlutamate receptor 1Homo sapiens (human)
recycling endosomeGlutamate receptor 1Homo sapiens (human)
recycling endosome membraneGlutamate receptor 1Homo sapiens (human)
excitatory synapseGlutamate receptor 1Homo sapiens (human)
synaptic membraneGlutamate receptor 1Homo sapiens (human)
presynapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
glutamatergic synapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density, intracellular componentGlutamate receptor 1Homo sapiens (human)
perisynaptic spaceGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
external side of plasma membraneGlutamate receptor 2Homo sapiens (human)
postsynaptic densityGlutamate receptor 2Homo sapiens (human)
dendriteGlutamate receptor 2Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 2Homo sapiens (human)
asymmetric synapseGlutamate receptor 2Homo sapiens (human)
neuronal cell bodyGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
excitatory synapseGlutamate receptor 2Homo sapiens (human)
postsynapseGlutamate receptor 2Homo sapiens (human)
postsynaptic endocytic zoneGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic membraneGlutamate receptor 3Homo sapiens (human)
parallel fiber to Purkinje cell synapseGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 3Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 3Homo sapiens (human)
dendritic spineGlutamate receptor 3Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendriteGlutamate receptor 4Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 4Homo sapiens (human)
neuronal cell bodyGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
extracellular vesicleGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 4Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 4Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
cytoplasmGlutamate carboxypeptidase 2Homo sapiens (human)
plasma membraneGlutamate carboxypeptidase 2Homo sapiens (human)
cell surfaceGlutamate carboxypeptidase 2Homo sapiens (human)
membraneGlutamate carboxypeptidase 2Homo sapiens (human)
extracellular exosomeGlutamate carboxypeptidase 2Homo sapiens (human)
plasma membraneGlutamate carboxypeptidase 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
dendrite cytoplasmGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
perikaryonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
mossy fiber rosetteGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
nucleusMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
dendriteMetabotropic glutamate receptor 1Homo sapiens (human)
Schaffer collateral - CA1 synapseMetabotropic glutamate receptor 1Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor dimeric complexMetabotropic glutamate receptor 1Homo sapiens (human)
G protein-coupled receptor homodimeric complexMetabotropic glutamate receptor 1Homo sapiens (human)
postsynaptic density membraneMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 1Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 2Homo sapiens (human)
axonMetabotropic glutamate receptor 2Homo sapiens (human)
dendriteMetabotropic glutamate receptor 2Homo sapiens (human)
presynaptic membraneMetabotropic glutamate receptor 2Homo sapiens (human)
astrocyte projectionMetabotropic glutamate receptor 2Homo sapiens (human)
glutamatergic synapseMetabotropic glutamate receptor 2Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 2Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 4Homo sapiens (human)
cytoplasmic vesicleMetabotropic glutamate receptor 4Homo sapiens (human)
presynapseMetabotropic glutamate receptor 4Homo sapiens (human)
plasma membraneMetabotropic glutamate receptor 4Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
nucleoplasmGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulumGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneCytochrome P450 3A43 Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
presynaptic active zone membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2DHomo sapiens (human)
neuronal cell bodyGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 3BHomo sapiens (human)
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
plasma membraneGlutamate receptor 1Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor 2Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 1 Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
intracellular membrane-bounded organelleGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
cell-cell junctionGlutamate receptor 1Homo sapiens (human)
cell surfaceGlutamate receptor 1Homo sapiens (human)
ER to Golgi transport vesicle membraneGlutamate receptor 1Homo sapiens (human)
postsynaptic densityGlutamate receptor 1Homo sapiens (human)
dendriteGlutamate receptor 1Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 1Homo sapiens (human)
synaptic vesicle membraneGlutamate receptor 1Homo sapiens (human)
neuromuscular junctionGlutamate receptor 1Homo sapiens (human)
early endosome membraneGlutamate receptor 1Homo sapiens (human)
dendritic spine membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell body membraneGlutamate receptor 1Homo sapiens (human)
endoplasmic reticulum-Golgi intermediate compartment membraneGlutamate receptor 1Homo sapiens (human)
neuronal cell bodyGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
dendritic shaftGlutamate receptor 1Homo sapiens (human)
axonal spineGlutamate receptor 1Homo sapiens (human)
neuron spineGlutamate receptor 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor 1Homo sapiens (human)
presynaptic active zone membraneGlutamate receptor 1Homo sapiens (human)
recycling endosomeGlutamate receptor 1Homo sapiens (human)
recycling endosome membraneGlutamate receptor 1Homo sapiens (human)
excitatory synapseGlutamate receptor 1Homo sapiens (human)
synaptic membraneGlutamate receptor 1Homo sapiens (human)
presynapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
glutamatergic synapseGlutamate receptor 1Homo sapiens (human)
postsynaptic density, intracellular componentGlutamate receptor 1Homo sapiens (human)
perisynaptic spaceGlutamate receptor 1Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 1Homo sapiens (human)
dendritic spineGlutamate receptor 1Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 1Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
external side of plasma membraneGlutamate receptor 2Homo sapiens (human)
postsynaptic densityGlutamate receptor 2Homo sapiens (human)
dendriteGlutamate receptor 2Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 2Homo sapiens (human)
asymmetric synapseGlutamate receptor 2Homo sapiens (human)
neuronal cell bodyGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
excitatory synapseGlutamate receptor 2Homo sapiens (human)
postsynapseGlutamate receptor 2Homo sapiens (human)
postsynaptic endocytic zoneGlutamate receptor 2Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 2Homo sapiens (human)
dendritic spineGlutamate receptor 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 2Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic membraneGlutamate receptor 3Homo sapiens (human)
parallel fiber to Purkinje cell synapseGlutamate receptor 3Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 3Homo sapiens (human)
plasma membraneGlutamate receptor 3Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 3Homo sapiens (human)
dendritic spineGlutamate receptor 3Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
basal plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
cell surfaceExcitatory amino acid transporter 1Homo sapiens (human)
membraneExcitatory amino acid transporter 1Homo sapiens (human)
cytoplasmic vesicleExcitatory amino acid transporter 1Homo sapiens (human)
neuron projectionExcitatory amino acid transporter 1Homo sapiens (human)
neuronal cell bodyExcitatory amino acid transporter 1Homo sapiens (human)
synapseExcitatory amino acid transporter 1Homo sapiens (human)
perinuclear region of cytoplasmExcitatory amino acid transporter 1Homo sapiens (human)
membrane protein complexExcitatory amino acid transporter 1Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 1Homo sapiens (human)
presynaptic membraneExcitatory amino acid transporter 2Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
cell surfaceExcitatory amino acid transporter 2Homo sapiens (human)
membraneExcitatory amino acid transporter 2Homo sapiens (human)
axolemmaExcitatory amino acid transporter 2Homo sapiens (human)
vesicleExcitatory amino acid transporter 2Homo sapiens (human)
cell bodyExcitatory amino acid transporter 2Homo sapiens (human)
neuron projection terminusExcitatory amino acid transporter 2Homo sapiens (human)
membrane raftExcitatory amino acid transporter 2Homo sapiens (human)
astrocyte projectionExcitatory amino acid transporter 2Homo sapiens (human)
glutamatergic synapseExcitatory amino acid transporter 2Homo sapiens (human)
membrane protein complexExcitatory amino acid transporter 2Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 2Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
endoplasmic reticulumExcitatory amino acid transporter 3Homo sapiens (human)
plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
cell surfaceExcitatory amino acid transporter 3Homo sapiens (human)
membraneExcitatory amino acid transporter 3Homo sapiens (human)
apical plasma membraneExcitatory amino acid transporter 3Homo sapiens (human)
axonExcitatory amino acid transporter 3Homo sapiens (human)
dendriteExcitatory amino acid transporter 3Homo sapiens (human)
early endosome membraneExcitatory amino acid transporter 3Homo sapiens (human)
late endosome membraneExcitatory amino acid transporter 3Homo sapiens (human)
asymmetric synapseExcitatory amino acid transporter 3Homo sapiens (human)
neuronal cell bodyExcitatory amino acid transporter 3Homo sapiens (human)
synaptic cleftExcitatory amino acid transporter 3Homo sapiens (human)
dendritic spineExcitatory amino acid transporter 3Homo sapiens (human)
dendritic shaftExcitatory amino acid transporter 3Homo sapiens (human)
perikaryonExcitatory amino acid transporter 3Homo sapiens (human)
axon terminusExcitatory amino acid transporter 3Homo sapiens (human)
membrane raftExcitatory amino acid transporter 3Homo sapiens (human)
recycling endosome membraneExcitatory amino acid transporter 3Homo sapiens (human)
extracellular exosomeExcitatory amino acid transporter 3Homo sapiens (human)
cell peripheryExcitatory amino acid transporter 3Homo sapiens (human)
glial cell projectionExcitatory amino acid transporter 3Homo sapiens (human)
apical dendriteExcitatory amino acid transporter 3Homo sapiens (human)
Schaffer collateral - CA1 synapseExcitatory amino acid transporter 3Homo sapiens (human)
presynapseExcitatory amino acid transporter 3Homo sapiens (human)
perisynaptic spaceExcitatory amino acid transporter 3Homo sapiens (human)
distal dendriteExcitatory amino acid transporter 3Homo sapiens (human)
proximal dendriteExcitatory amino acid transporter 3Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendriteGlutamate receptor 4Homo sapiens (human)
endocytic vesicle membraneGlutamate receptor 4Homo sapiens (human)
neuronal cell bodyGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
extracellular vesicleGlutamate receptor 4Homo sapiens (human)
AMPA glutamate receptor complexGlutamate receptor 4Homo sapiens (human)
postsynaptic density membraneGlutamate receptor 4Homo sapiens (human)
plasma membraneGlutamate receptor 4Homo sapiens (human)
dendritic spineGlutamate receptor 4Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2A Rattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2CRattus norvegicus (Norway rat)
cytoplasmGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic vesicleGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendriteGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic cleftGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
dendritic spineGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
excitatory synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 1Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic vesicleGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
cytoplasmic vesicle membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
dendritic spineGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
dendrite cytoplasmGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
perikaryonGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
mossy fiber rosetteGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 2Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
axonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
dendriteGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
dendrite cytoplasmGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
terminal boutonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
perikaryonGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 3Homo sapiens (human)
cytoplasmGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
lysosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
late endosomeGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cytoskeletonGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
cell surfaceGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic densityGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
synaptic membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2BHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
postsynaptic membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 2CHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 4Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
nucleoplasmGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulumGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
hippocampal mossy fiber to CA3 synapseGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
presynaptic membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
plasma membraneGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
kainate selective glutamate receptor complexGlutamate receptor ionotropic, kainate 5Homo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 2DRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
neuron projectionGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
neuronal cell bodyGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
synapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
presynapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
glutamatergic synapseGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
NMDA selective glutamate receptor complexGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
plasma membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
postsynaptic density membraneGlutamate receptor ionotropic, NMDA 3AHomo sapiens (human)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3BRattus norvegicus (Norway rat)
endoplasmic reticulum membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
plasma membraneGlutamate receptor ionotropic, NMDA 3ARattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (213)

Assay IDTitleYearJournalArticle
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID1347154Primary screen GU AMC qHTS for Zika virus inhibitors2020Proceedings of the National Academy of Sciences of the United States of America, 12-08, Volume: 117, Issue:49
Therapeutic candidates for the Zika virus identified by a high-throughput screen for Zika protease inhibitors.
AID1553739Displacement of (RS)-[3H]AMPA from recombinant rat GluA2(R) expressed in baculovirus infected Sf9 insect cell membranes2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
AID92497Inhibition of specific binding of [3H]AMPA to Ionotropic glutamate receptor AMPA in rat brain membranes1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.
AID26846The dissociation constant at omega-carboxyl or hydroxyl group in water at 20 degree Centigrade.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID129523In Vivo evaluation of the Compound administered through icv for the for tonicity in presence along with the antagonist GYKI 52466 in mice1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID26634The dissociation constant at alpha-carboxyl group in water at 20 degree Centigrade. (evaluated by Harrision et. al.)1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID239017Binding affinity for ionotropic Glutamate receptor AMPA 3 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID231234Potency ratio (the ratio between the CD50 value of the drug in the presence of antagonist versus its CD50 value) for compound in presence of CPP compound in presence of NBQX; range 3.8-5.41998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID26871The dissociation constant at ammonium group in water at 20 degree Centigrade.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID144470Binding affinity against N-methyl-D-aspartate glutamate receptor using [3H]-CPP as radioligand.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID92951Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 1 expressed in HEK293 cells1997Journal of medicinal chemistry, Oct-24, Volume: 40, Issue:22
Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
AID541690Displacement of [3H[AMPA from rat recombinant GluA4o expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID129397Convulsant property on icv (intracervical) injection measured as tonus seizures in mouse.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID541691Displacement of [3H[SYM2081 from rat recombinant GluK1(Q)1b expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID93254Displacement of [3H]kainate from human Ionotropic glutamate receptor ionotropic kainate 1 expressed in HEK293 cells1997Journal of medicinal chemistry, Oct-24, Volume: 40, Issue:22
Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
AID108656Agonist activity of the compound at Metabotropic Excitatory Amino acid Receptors Expressed in CHO cells. mGlu1-alpha1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID26872The dissociation constant at ammonium group in water at 20 degree Centigrade. (evaluated by Harrision et. al.)1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID93720Inhibitory activity against Ionotropic glutamate receptor kainate using [3H]-kainic acid as radioligand1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
AID93719Inhibition of specific binding of [3H]kainate to Ionotropic glutamate receptor kainate in rat brain membranes1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.
AID26633The dissociation constant at alpha-carboxyl group in water at 20 degree Centigrade.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID187287GDEE-sensitive neuronal excitant (Relative potency) was evaluated;1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID145036The compound was evaluated for agonist to competitive inhibition of radioligand ([3H]- MK -801) at Ionotropic Excitatory Amino acid receptors1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID143143Ability to displace [3H]CGP-39653 radioligand at N-methyl-D-aspartate glutamate receptor in rat cortical membranes2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
AID144607Compound was evaluated for binding affinity at N-methyl-D-aspartate glutamate receptor using [3H]CPP as radioligand1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID144993Tested in vitro for the concentration required to inhibit [3H]CPP radioligand at EAA receptor sites in rat cortical membranes at 100 uM1994Journal of medicinal chemistry, Sep-30, Volume: 37, Issue:20
Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands.
AID109010Agonist activity of the compound at Metabotropic Excitatory Amino acid Receptors Expressed in CHO cells. mGlu21996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID196568Electropharmacology on rat cortical slice preparation for EAA-evoked depolarizations; Depolarization evoked by the compound is fully antagonised by 5 uM of NBQX.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID246396In vitro activity at Ionotropic glutamate receptor using cortical wedge assays in rat brain synaptosoma2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID144902Inhibitory activity against N-methyl-D-aspartate glutamate receptor using [3H]CPP as radioligand1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
AID92354Compound was evaluated for binding affinity at Ionotropic glutamate receptor AMPA using [3H]AMPA as radioligand1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID239016Binding affinity for ionotropic Glutamate receptor AMPA 2 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID1553740Displacement of (RS)-[3H]AMPA from recombinant rat GluA3 expressed in baculovirus infected Sf9 insect cell membranes2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
AID129400In Vivo evaluation of the Compound administered through icv for the Clonic seizure presence along with the antagonist GYKI 52466 in mice.1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID93111Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 4 expressed in HEK293 cells1997Journal of medicinal chemistry, Oct-24, Volume: 40, Issue:22
Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
AID92962Displacement of [3H]AMPA from human Ionotropic glutamate receptor AMPA 2 expressed in HEK293 cells1997Journal of medicinal chemistry, Oct-24, Volume: 40, Issue:22
Synthesis of willardiine and 6-azawillardiine analogs: pharmacological characterization on cloned homomeric human AMPA and kainate receptor subtypes.
AID93558Binding affinity against Ionotropic glutamate receptor kainate using [3H]KAIN as radioligand.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID31586Tested in vitro for the concentration required to inhibit [3H]AMPA radioligand at AMPA receptor sites in rat cortical membranes1994Journal of medicinal chemistry, Sep-30, Volume: 37, Issue:20
Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands.
AID145250NMDA Antagonist activity was evaluated; na means no activity1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID93554Ability to inhibit the binding of [3H]-kainic acid radioligand to Ionotropic glutamate receptor kainate in rat brain membranes.1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
AID129531In Vivo evaluation of the Compound administered through icv for tonicity in presence alone in mice1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID129524In Vivo evaluation of the Compound administered through icv for the for tonicity in presence along with the radioligand [3H]- CPP in mice1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID92505The compound was evaluated for agonist to competitive inhibition of radioligand ([3H]- AMPA ) at Ionotropic glutamate receptor AMPA1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID541688Displacement of [3H[AMPA from rat recombinant GluA2(R)o expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID231242Potency ratio (the ratio between the CD50 value of the drug in the presence of antagonist versus its CD50 value) for compound in presence of GYKI 52466; range 4.3-5.51998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID242344Displacement of [3H]KA from glutamate receptor of rat brain synaptosomes2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID541692Displacement of [3H[SYM2081 from rat recombinant GluK2(VCR)a expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID177860Effective dose against rat cortical slice cells using Electrophysiological experiment.1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
AID107254Agonist activity of the compound at Metabotropic Excitatory Amino acid Receptors Expressed in CHO cells. mGlu61996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID92501Tested for inhibition of Specific DL-[H]Ionotropic glutamate receptor AMPA binding to rat brain membranes1983Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
Enzymic resolution and binding to rat brain membranes of the glutamic acid agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.
AID129398In Vivo evaluation of the Compound administered through icv for the Clonic seizure presence alone in mice.1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID239018Binding affinity for ionotropic Glutamate receptor AMPA 4 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID422593Displacement of [3H]KA from KA receptor in rat cortical synaptosomes2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
AID92195The compound (AMPA agonist) was evaluated for agonist activity at Ionotropic glutamate receptor AMPA in cortical wedge.1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID538681Displacement of [3H]AMPA from AMPA receptor in Sprague-Dawley rat brain cortex after 30 mins by competitive binding assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
1,2,3-triazolyl amino acids as AMPA receptor ligands.
AID231237Potency ratio (the ratio between the CD50 value of the drug in the presence of antagonist versus its CD50 value) for compound in presence of CPP; range 1.1-1.51998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID541687Displacement of [3H[AMPA from rat recombinant GluA1o expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID92212Binding affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA as radioligand.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID175684Effective concentration in vitro as electropharmacological activity in the rat cortical wedge preparation1994Journal of medicinal chemistry, Sep-30, Volume: 37, Issue:20
Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands.
AID92795Ability to inhibit the binding of [3H]AMPA radioligand to Ionotropic glutamate receptor AMPA in rat brain membranes.1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
AID538682Displacement of [3H]KAIN from kainate receptor in Sprague-Dawley rat brain cortex after 60 mins by competitive binding assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
1,2,3-triazolyl amino acids as AMPA receptor ligands.
AID144319Compound was evaluated for the affinity of the N-methyl-D-aspartate glutamate receptor at 10 uM, partially antagonized by 5 uM NBQX and fully antagonized by 20 uM NBQX.1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID129519In Vivo evaluation of the Compound administered through icv for the Clonic seizure presence along with the radioligand [3H]- CPP in mice.1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID422594Displacement of [3H]CGP from NMDA receptor in rat cortical synaptosomes2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
AID242408Displacement of [3H]AMPA from Ionotropic glutamate receptor of in rat brain synaptosomes2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID144826Inhibition of [3H]-MK-801 binding to EAA receptor sites in rat cortical membranes1994Journal of medicinal chemistry, Sep-30, Volume: 37, Issue:20
Synthesis and structure-activity studies on acidic amino acids and related diacids as NMDA receptor ligands.
AID129521In Vivo evaluation of the Compound administered through icv for the Clonic seizure presence of the compound along with the antagonist NBQX in mice1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID239056Binding affinity for kainate Glutamate receptor GluR6 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID93725The compound was evaluated for agonist to competitive inhibition of radioligand ([3H]- kainic acid ) at Ionotropic glutamate receptor kainate1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID239055Binding affinity for kainate Glutamate receptor GluR5 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID175858In vitro stimulation of norepinephrine release from hippocampal nerve endings.1997Journal of medicinal chemistry, Sep-26, Volume: 40, Issue:20
Structure--activity studies for alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropanoic acid receptors: acidic hydroxyphenylalanines.
AID239518Displacement of [3H]-CGP- 39653 from N-methyl-D-aspartate glutamate receptor of rat brain synaptosomes2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID422592Displacement of [3H]AMPA from AMPA receptor in rat cortical synaptosomes2009Journal of medicinal chemistry, Aug-13, Volume: 52, Issue:15
The glutamate receptor GluR5 agonist (S)-2-amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid and the 8-methyl analogue: synthesis, molecular pharmacology, and biostructural characterization.
AID109481Agonist activity of the compound at Metabotropic Excitatory Amino acid Receptors Expressed in CHO cells. mGlu4a1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID26847The dissociation constant at omega-carboxyl or hydroxyl group in water at 20 degree Centigrade. (evaluated by Harrision et. al.)1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID129525In Vivo evaluation of the Compound administered through icv for the for tonicity in presence of the compound along with the antagonist NBQX in mice1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID1553741Displacement of (RS)-[3H]AMPA from recombinant rat GluA4 expressed in baculovirus infected Sf9 insect cell membranes2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
AID257200Displacement of [3H](S)-5-fluorowillardiine from AMPA receptor in rat brain membrane2005Journal of medicinal chemistry, Dec-01, Volume: 48, Issue:24
Synthesis and pharmacology of willardiine derivatives acting as antagonists of kainate receptors.
AID92499Inhibitory activity against Ionotropic glutamate receptor AMPA using [3H]AMPA as radioligand1996Journal of medicinal chemistry, Jan-05, Volume: 39, Issue:1
N-methyl-D-aspartic acid receptor agonists: resolution, absolute stereochemistry, and pharmacology of the enantiomers of 2-amino-2-(3-hydroxy-5-methyl-4-isoxazolyl)acetic acid.
AID541693Displacement of [3H[SYM2081 from rat recombinant GluK3a expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID541689Displacement of [3H[AMPA from rat recombinant GluA3o expressed in sS9 cells2010Journal of medicinal chemistry, Dec-09, Volume: 53, Issue:23
Biostructural and pharmacological studies of bicyclic analogues of the 3-isoxazolol glutamate receptor agonist ibotenic acid.
AID93570Compound was evaluated for binding affinity at Ionotropic glutamate receptor kainate using [3H]- KAIN as radioligand1998Journal of medicinal chemistry, Sep-24, Volume: 41, Issue:20
Synthesis and pharmacology of a new AMPA-kainate receptor agonist with potent convulsant activity.
AID179948Inhibition of [3H]AMPA binding in rat brain membrane was evaluated1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID338170Displacement of [3H]AMPA from quisqualate receptor assessed as specific binding relative to total binding1993Journal of natural products, Apr, Volume: 56, Issue:4
The role of receptor binding in drug discovery.
AID1553742Displacement of (RS)-[3H]AMPA from recombinant rat GluA2-ABD expressed in baculovirus infected Sf9 insect cell membranes2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
AID144459Ability to inhibit the binding of [3H]CPP radioligand to N-methyl-D-aspartate glutamate receptor in rat brain membranes.1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
AID143459The compound was evaluated for agonist to competitive inhibition of radioligand ([3H]- CPP ) at Ionotropic Excitatory Amino acid receptors1996Journal of medicinal chemistry, Aug-02, Volume: 39, Issue:16
A new highly selective metabotropic excitatory amino acid agonist: 2-amino-4-(3-hydroxy-5-methylisoxazol-4-yl)butyric acid.
AID239015Binding affinity for ionotropic Glutamate receptor AMPA 1 expressed in Sf9 cells2005Journal of medicinal chemistry, May-05, Volume: 48, Issue:9
Convergent synthesis and pharmacology of substituted tetrazolyl-2-amino-3-(3-hydroxy-5-methyl-4-isoxazolyl)propionic acid analogues.
AID337886Displacement of [3H]AMPA from quisqualate receptor1993Journal of natural products, Apr, Volume: 56, Issue:4
The role of receptor binding in drug discovery.
AID92794Agonist effect for Ionotropic glutamate receptor AMPA was determined from in vitro electrophysiology studies using rat cortical wedge preparation.1998Journal of medicinal chemistry, Jul-02, Volume: 41, Issue:14
Heteroaryl analogues of AMPA. 2. Synthesis, absolute stereochemistry, photochemistry, and structure-activity relationships.
AID1553738Displacement of (RS)-[3H]AMPA from recombinant rat GluA1 expressed in baculovirus infected Sf9 insect cell membranes2019Journal of medicinal chemistry, 05-09, Volume: 62, Issue:9
Use of the 4-Hydroxytriazole Moiety as a Bioisosteric Tool in the Development of Ionotropic Glutamate Receptor Ligands.
AID456223Inhibition of amino acid transport system xc- in rat LRM55 cells assessed as [3H]L-glutamate uptake at 500 uM by liquid scintillation counting2010Bioorganic & medicinal chemistry, Jan-01, Volume: 18, Issue:1
Isoxazole analogues bind the system xc- transporter: structure-activity relationship and pharmacophore model.
AID538680Displacement of [3H]CGP39653 from NMDA receptor in Sprague-Dawley rat brain cortex after 60 mins by competitive binding assay2010Bioorganic & medicinal chemistry letters, Dec-15, Volume: 20, Issue:24
1,2,3-triazolyl amino acids as AMPA receptor ligands.
AID93117Ability to displace [3H]-kainic acid radioligand at kainate receptor in rat cortical membranes2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
AID92198Ability to displace [3H]AMPA radioligand at Ionotropic glutamate receptor AMPA in rat cortical membranes2003Journal of medicinal chemistry, Apr-10, Volume: 46, Issue:8
(S)-2-Amino-3-(3-hydroxy-7,8-dihydro-6H-cyclohepta[d]isoxazol-4-yl)propionic acid, a potent and selective agonist at the GluR5 subtype of ionotropic glutamate receptors. Synthesis, modeling, and molecular pharmacology.
AID129396Convulsant property on icv (intracervical) injection measured as clonus seizures in mouse.1999Journal of medicinal chemistry, Oct-07, Volume: 42, Issue:20
Synthesis and enantiopharmacology of new AMPA-kainate receptor agonists.
AID1797641Determination of Inhibition Concentration Values (IC50) from Article 10.1021/jm070133w: \\Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.\\2007Journal of medicinal chemistry, Jul-12, Volume: 50, Issue:14
Structural insight into the pharmacophore pocket of human glutamate carboxypeptidase II.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2000Neuron, Oct, Volume: 28, Issue:1
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
AID1811Experimentally measured binding affinity data derived from PDB2000Neuron, Oct, Volume: 28, Issue:1
Mechanisms for activation and antagonism of an AMPA-sensitive glutamate receptor: crystal structures of the GluR2 ligand binding core.
AID1811Experimentally measured binding affinity data derived from PDB2003Proceedings of the National Academy of Sciences of the United States of America, May-13, Volume: 100, Issue:10
Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
AID977611Experimentally measured binding affinity data (Kd) for protein-ligand complexes derived from PDB2003Proceedings of the National Academy of Sciences of the United States of America, May-13, Volume: 100, Issue:10
Tuning activation of the AMPA-sensitive GluR2 ion channel by genetic adjustment of agonist-induced conformational changes.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347049Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot screen2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347083qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: Viability assay - alamar blue signal for LASV Primary Screen2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID1347045Natriuretic polypeptide receptor (hNpr1) antagonism - Pilot counterscreen GloSensor control cell line2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1347050Natriuretic polypeptide receptor (hNpr2) antagonism - Pilot subtype selectivity assay2019Science translational medicine, 07-10, Volume: 11, Issue:500
Inhibition of natriuretic peptide receptor 1 reduces itch in mice.
AID1508630Primary qHTS for small molecule stabilizers of the endoplasmic reticulum resident proteome: Secreted ER Calcium Modulated Protein (SERCaMP) assay2021Cell reports, 04-27, Volume: 35, Issue:4
A target-agnostic screen identifies approved drugs to stabilize the endoplasmic reticulum-resident proteome.
AID504836Inducers of the Endoplasmic Reticulum Stress Response (ERSR) in human glioma: Validation2002The Journal of biological chemistry, Apr-19, Volume: 277, Issue:16
Sustained ER Ca2+ depletion suppresses protein synthesis and induces activation-enhanced cell death in mast cells.
AID588378qHTS for Inhibitors of ATXN expression: Validation
AID1347086qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lymphocytic Choriomeningitis Arenaviruses (LCMV): LCMV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID588349qHTS for Inhibitors of ATXN expression: Validation of Cytotoxic Assay
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1347082qHTS for Inhibitors of the Functional Ribonucleoprotein Complex (vRNP) of Lassa (LASV) Arenavirus: LASV Primary Screen - GLuc reporter signal2020Antiviral research, 01, Volume: 173A cell-based, infectious-free, platform to identify inhibitors of lassa virus ribonucleoprotein (vRNP) activity.
AID286979Displacement of [3H]AMPA from rat recombinant GluR4 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID92955Effective concentration of compound was determined for electrophysiological properties on Ionotropic glutamate receptor AMPA 1 using rat cortical slice model in Xenopus laevis oocytes2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID92051Concentration required for 50% inhibition of [3H]Glu binding to AMPA receptor in rat cortical slice preparation in the presence of 2.5 mM CaCl21992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
AID92365Concentration required for 50% inhibition of [3H]AMPA binding to AMPA receptor in rat cortical slice preparation1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
AID29184Pka value of carboxyl group determined by potentiometric method2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID25307Acid dissociation constant was calculated based on carbon atom COOH1997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID92807Inhibition of the binding of radioligand [3H]AMPA in the presence at high-affinity AMPA receptor sites.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
AID391447Displacement of [3H]kainic acid from rat recombinant iGluR6(V,C,R) receptor expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID144186Agonistic activity at N-methyl-D-aspartate glutamate receptor was measured as [Ca2+] influx in rat cerebellar granule neurons at 30 uM concentration1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
AID286978Displacement of [3H]AMPA from rat recombinant GluR3 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID92048Compound was tested for in vitro binding affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA ligand1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
AID286977Displacement of [3H]AMPA from rat recombinant GluR2 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID113190In vivo convulsant activity were tested in mice after subcutaneous administration.1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
AID227653In vitro excitatory activity expressed as EC50 was measured in the rat cortical slice model.1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA.
AID180056Neuroprotective effect evaluated for excitatory amino acid receptor antagonism with the concentration at 1 uL in the corpus striatum of 14 rats with choline acetyltransferase as the marker enzyme.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
AID93115Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor AMPA 4 (GluR4) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID144758Concentration required for 50% inhibition of [3H]-CPP binding to N-methyl-D-aspartate glutamate receptor in rat cortical slice preparation1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
AID75668Measure of synaptosomal Glu uptake system using [3H]- -D-aspartic acid as radioligand.2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID95528Compound was evaluated for the inhibition of binding of [3H]-Kainic acid to kianic acid receptor1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID477141Agonist activity at rat recombinant GluA4 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID71159Binding affinity for Excitatory amino acid transporter 1 (EAAT-1) in Glu uptake system2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID144838Compound was evaluated for the inhibition of binding of [3H]- CPP to NMDA receptor1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID93564Binding affinity was measured by [3H]- Ionotropic glutamate receptor ionotropic kainate binding assay.1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA.
AID92342Binding affinity at Ionotropic glutamate receptor AMPA, using [3H]AMPA receptor binding assay.1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA.
AID478464Displacement of [3H]CGP39653 from NMDA receptor in Sprague-Dawley rat brain membranes2010Journal of medicinal chemistry, May-27, Volume: 53, Issue:10
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
AID26367pKa value by 1H NMR titration experiments; pK31996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
AID143450In vitro binding affinity against N-methyl-D-aspartate glutamate receptor using [3H]-CPG 39653 as radioligand1997Journal of medicinal chemistry, Aug-29, Volume: 40, Issue:18
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
AID143462Binding affinity of compound was determined against N-methyl-D-aspartate glutamate receptor, using radioligand [3H]- CGP-396532003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID31459Compound was evaluated for the inhibition of binding of [3H]AMPA to the AMPA receptor1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID477140Agonist activity at rat recombinant GluA3 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID29182Pka value of Amino group determined by potentiometric method2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID139966Neurotoxicity was determined in cultured mouse cortical neurons2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID93406Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor ionotropic kainate 6 (GluR6) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID93098Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor AMPA 2 (GluR2) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID92959Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor AMPA 1 (GluR1) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID26366pKa value by 1H NMR titration experiments; pK21996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
AID391442Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR1 expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID391445Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR4 expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID92344Binding affinity for Ionotropic glutamate receptor AMPA using [3H]- AMPA2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID144759Concentration required for 50% inhibition of [3H]-MK-801 binding to N-methyl-D-aspartate glutamate receptor in rat cortical slice preparation1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
AID175657EC50 value was measured in rat cortical wedge preparation2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID92934Percentage binding at high-affinity AMPA receptor sites.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
AID92368In vitro binding affinity for Ionotropic glutamate receptor AMPA site was determined using [3H]AMPA as radioligand in rat cortex1997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID286982Activity at ionotropic GluR in rat cortical wedge by electrophysiology assay2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID196562Electrophysiological study in rat cortical slice model1997Journal of medicinal chemistry, Aug-29, Volume: 40, Issue:18
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
AID286972Displacement of [3H]CGP 39653 from NMDA receptor in rat synaptosomes2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID144839Compound was evaluated for the inhibition of binding of [3H]- MK-801 to NMDA receptor1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID92930Inhibition of the binding of radioligand [3H]AMPA in the presence at low-affinity AMPA receptor sites.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
AID197547The compound was evaluated for agonist sensitivity to antagonist R-APPA1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID92944Binding affinity of compound was determined against Ionotropic glutamate receptor AMPA receptor, using radioligand [3H]- AMPA2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID145264Compound was evaluated for the inhibition of binding of [3H]glycine to NMDA receptor1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID391443Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR2(R) expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID92935Percentage binding at low-affinity AMPA receptor sites.1991Journal of medicinal chemistry, Jan, Volume: 34, Issue:1
Novel class of amino acid antagonists at non-N-methyl-D-aspartic acid excitatory amino acid receptors. Synthesis, in vitro and in vivo pharmacology, and neuroprotection.
AID93103Effective concentration of compound was determined for electrophysiological properties on Ionotropic glutamate receptor AMPA 3 (GluR3) using rat cortical slice model in Xenopus laevis oocytes2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID477147Agonist activity at recombinant GluA2A4 receptor flip isoform expressed in Xenopus oocytes2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID286980Displacement of [3H]SYM 2081 from rat recombinant GluR5 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID286971Displacement of [3H]KA from kainate receptor in rat synaptosomes2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID477146Agonist activity at recombinant GluA1A2 receptor flip isoform expressed in Xenopus oocytes2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID29183Pka value of bioisostere group determined by potentiometric method2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID391444Displacement of (R,S)-[5-methyl-3H]AMPA from rat recombinant flop iGluR3 expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID25308Acid dissociation constant was calculated based on carbon atom alpha-CH1997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID92501Tested for inhibition of Specific DL-[H]Ionotropic glutamate receptor AMPA binding to rat brain membranes1983Journal of medicinal chemistry, Jun, Volume: 26, Issue:6
Enzymic resolution and binding to rat brain membranes of the glutamic acid agonist alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid.
AID93712Concentration required for 50% inhibition of [3H]-kainic acid binding to ionotropic glutamate receptor ionotropic kainate in rat cortical slice preparation1992Journal of medicinal chemistry, Sep-18, Volume: 35, Issue:19
Excitatory amino acid receptor ligands. Synthesis and biological activity of 3-isoxazolol amino acids structurally related to homoibotenic acid.
AID477139Agonist activity at rat recombinant GluA2 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID478462Displacement of [3H]AMPA from AMPA receptor in Sprague-Dawley rat brain membranes2010Journal of medicinal chemistry, May-27, Volume: 53, Issue:10
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
AID197546The compound was evaluated for agonist sensitivity to antagonist NBQX1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID179948Inhibition of [3H]AMPA binding in rat brain membrane was evaluated1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID92197Antagonism of Ionotropic glutamate receptor AMPA action was measured as [Ca2+] influx in rat cerebellar granule neurons at 1 uM concentration1998Journal of medicinal chemistry, May-07, Volume: 41, Issue:10
Synthesis and biology of the conformationally restricted ACPD analogue, 2-aminobicyclo[2.1.1]hexane-2,5-dicarboxylic acid-I, a potent mGluR agonist.
AID391446Displacement of [3H]SYM2081 from rat recombinant iGluR5(Q)1b expressed in Sf9 cells2008Journal of medicinal chemistry, Oct-23, Volume: 51, Issue:20
1H-cyclopentapyrimidine-2,4(1H,3H)-dione-related ionotropic glutamate receptors ligands. structure-activity relationships and identification of potent and Selective iGluR5 modulators.
AID196574Compound was tested for electrophysiological experiments using rat cortical wedge preparation1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
AID196384Effective concentration evaluated in electrophysiological rat cortical slice model1997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID93568Inhibition of [3H]- Kainate binding to Ionotropic glutamate receptor kainate in brain homogenates.1996Journal of medicinal chemistry, Oct-25, Volume: 39, Issue:22
Synthesis of chiral 1-(2'-amino-2'-carboxyethyl)-1,4-dihydro-6,7-quinoxaline-2,3-diones: alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptor agonists and antagonists.
AID143782Binding affinity was measured by N-methyl-D-aspartate glutamate receptor 1/2A/2B/2C/2D binding assay.1992Journal of medicinal chemistry, Jan, Volume: 35, Issue:1
Heterocyclic excitatory amino acids. Synthesis and biological activity of novel analogues of AMPA.
AID175671Effective concentration of compound was determined for electrophysiological properties on iGluRs using rat cortical slice model in Xenopus laevis oocytes2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID143152Binding affinity for N-methyl-D-aspartate glutamate receptor (NMDA) using [3H]- CPP2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID71163Binding affinity for Excitatory amino acid transporter 3 (EAAT-3) in Glu uptake system2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID108343In vitro binding affinity against Metabotropic glutamate receptor using [3H](S)-glutamic acid1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
AID477118Agonist activity at rat recombinant GluA3 receptor flop isoform expressed in Xenopus oocytes2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID93257Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor ionotropic kainate 1 (GluR5) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID145251NMDA Antagonist activity was evaluated; na means no activity; na means no activity1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID112672In vivo anti-convulsant activity were tested in mice after intravenous administration.1998Journal of medicinal chemistry, Mar-12, Volume: 41, Issue:6
Excitatory amino acid receptor ligands: resolution, absolute stereochemistry, and enantiopharmacology of 2-amino-3-(4-butyl-3-hydroxyisoxazol-5-yl)propionic acid.
AID93116Binding affinity for Ionotropic glutamate receptor using [3H]- kainic acid2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID91459In vitro binding affinity against Ionotropic glutamate receptor kainate (kainic acid) using [3H]KAIN as radioligand1997Journal of medicinal chemistry, Aug-29, Volume: 40, Issue:18
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
AID286970Displacement of [3H]AMPA from AMPA receptor in rat synaptosomes2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID93106Binding affinity of compound was determined towards cloned Ionotropic glutamate receptor AMPA 3 (GluR3) expressed in Sf 9 insect cells2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID477117Agonist activity at rat recombinant GluA1 receptor flop isoform expressed in Xenopus oocytes2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID26365pKa value by 1H NMR titration experiments; pK11996Journal of medicinal chemistry, Jan-19, Volume: 39, Issue:2
Syntheses and conformational analyses of glutamate analogs: 2-(2-carboxy-3-substituted-cyclopropyl)glycines as useful probes for excitatory amino acid receptors.
AID187290GDEE-sensitive neuronal excitant (Relative potency) was evaluated; +++1985Journal of medicinal chemistry, May, Volume: 28, Issue:5
Ibotenic acid analogues. Synthesis, molecular flexibility, and in vitro activity of agonists and antagonists at central glutamic acid receptors.
AID286981Displacement of [3H]KA from rat recombinant GluR6 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID31454Compound was evaluated for the agonist activity on AMPA receptor in rat cortical wedge preparation1994Journal of medicinal chemistry, Apr-01, Volume: 37, Issue:7
Resolution, absolute stereochemistry, and pharmacology of the S-(+)- and R-(-)-isomers of the apparent partial AMPA receptor agonist (R,S)-2-amino-3-(3-hydroxy-5-phenylisoxazol-4-yl)propionic acid [(R,S)-APPA].
AID477138Agonist activity at rat recombinant GluA1 receptor flip isoform expressed in HEK293 cells assessed as effect on cyclothiazide-induced calcium flux by Fluo-4/AM staining-based fluorescence assay2010Bioorganic & medicinal chemistry, Feb-15, Volume: 18, Issue:4
Developing a complete pharmacology for AMPA receptors: a perspective on subtype-selective ligands.
AID25303Acid dissociation constant was calculated based on carbon atom C31997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID113192In vivo convulsant potency after subcutaneous administration in mice1997Journal of medicinal chemistry, Feb-14, Volume: 40, Issue:4
AMPA receptor agonists: synthesis, protolytic properties, and pharmacology of 3-isothiazolol bioisosteres of glutamic acid.
AID286976Displacement of [3H]AMPA from rat recombinant GluR1 expressed in Sf9 cells2007Journal of medicinal chemistry, May-17, Volume: 50, Issue:10
A tetrazolyl-substituted subtype-selective AMPA receptor agonist.
AID93126Binding affinity of compound was determined against Ionotropic glutamate receptor ionotropic kainate, using radioligand [3H]- KA2003Journal of medicinal chemistry, May-22, Volume: 46, Issue:11
Design, synthesis, and pharmacology of a highly subtype-selective GluR1/2 agonist, (RS)-2-amino-3-(4-chloro-3-hydroxy-5-isoxazolyl)propionic acid (Cl-HIBO).
AID71161Binding affinity for Excitatory amino acid transporter 2 (EAAT-2) in Glu uptake system2002Journal of medicinal chemistry, Jan-03, Volume: 45, Issue:1
Novel 1-hydroxyazole bioisosteres of glutamic acid. Synthesis, protolytic properties, and pharmacology.
AID92806In vitro binding affinity against Ionotropic glutamate receptor AMPA using [3H]AMPA as radioligand1997Journal of medicinal chemistry, Aug-29, Volume: 40, Issue:18
Heteroaryl analogues of AMPA. Synthesis and quantitative structure-activity relationships.
AID478463Displacement of [3H]KA from KA receptor in Sprague-Dawley rat brain membranes2010Journal of medicinal chemistry, May-27, Volume: 53, Issue:10
4-hydroxy-1,2,5-oxadiazol-3-yl moiety as bioisoster of the carboxy function. Synthesis, ionization constants, and molecular pharmacological characterization at ionotropic glutamate receptors of compounds related to glutamate and its homologues.
AID602156Novartis GNF Liver Stage Dataset: Malariabox Annotation2011Science (New York, N.Y.), Dec-09, Volume: 334, Issue:6061
Imaging of Plasmodium liver stages to drive next-generation antimalarial drug discovery.
AID1159607Screen for inhibitors of RMI FANCM (MM2) intereaction2016Journal of biomolecular screening, Jul, Volume: 21, Issue:6
A High-Throughput Screening Strategy to Identify Protein-Protein Interaction Inhibitors That Block the Fanconi Anemia DNA Repair Pathway.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (2,858)

TimeframeStudies, This Drug (%)All Drugs %
pre-199080 (2.80)18.7374
1990's1225 (42.86)18.2507
2000's870 (30.44)29.6817
2010's443 (15.50)24.3611
2020's240 (8.40)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.37

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.37 (24.57)
Research Supply Index7.98 (2.92)
Research Growth Index5.80 (4.65)
Search Engine Demand Index22.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.37)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Trials11 (0.38%)5.53%
Reviews1 (4.17%)6.00%
Reviews81 (2.79%)6.00%
Case Studies0 (0.00%)4.05%
Case Studies8 (0.28%)4.05%
Observational0 (0.00%)0.25%
Observational0 (0.00%)0.25%
Other23 (95.83%)84.16%
Other2,799 (96.55%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Clinical Trials (1)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
A Multinational, Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Assess the Efficacy, Tolerability and Safety of Talampanel in Subjects With Amyotrophic Lateral Sclerosis (ALS) [NCT00696332]Phase 2559 participants (Actual)Interventional2008-09-30Completed
[information is prepared from clinicaltrials.gov, extracted Sep-2024]